Skip to main content

New Mountain Finance Corp

For the period ended Sep 30, 2026. Filed Nov 2, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 2, 2026

NMFC$6.88-0.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to the Consolidated Financial Statements of New Mountain Finance Corporation (unaudited)

Notes to the Consolidated Financial Statements of

Note 1. Formation and Business Purpose

New Mountain Finance Corporation (“NMFC” or the “Company”) is a Delaware corporation that was originally incorporated on June 29, 2010 and completed its initial public offering ("IPO") on May 19, 2011. NMFC is a closed-end, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). NMFC has elected to be treated, and intends to comply with the requirements to continue to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). Since NMFC’s IPO, and through September 30, 2026, NMFC has raised approximately $1,034,550 in net proceeds from additional offerings of its common stock.

New Mountain Finance Advisers, L.L.C. (the “Investment Adviser”), formerly known as New Mountain Finance Advisers BDC, L.L.C., is a wholly-owned subsidiary of New Mountain Capital Group, L.P. (together with New Mountain Capital, L.L.C. and its affiliates, "New Mountain Capital"), whose ultimate owners include Steven B. Klinsky, other current and former New Mountain Capital professionals and related vehicles and a minority investor. New Mountain Capital is a global investment firm with approximately $60 billion of assets under management and a track record of investing in the middle market. New Mountain Capital focuses on investing in defensive growth companies across its private equity, credit and net lease investment strategies. The Investment Adviser manages the Company's day-to-day operations and provides it with investment advisory and management services. The Investment Adviser also manages other funds that may have investment mandates that are similar, in whole or in part, to the Company's. New Mountain Finance Administration, L.L.C. (the "Administrator"), a wholly-owned subsidiary of New Mountain Capital, provides the administrative services necessary to conduct the Company's day-to-day operations.

The Company has established the following wholly-owned direct and indirect subsidiaries:

New Mountain Finance Holdings, L.L.C. ("NMF Holdings"), whose assets are used to secure NMF Holdings’ credit facility;

New Mountain Finance SBIC, L.P. ("SBIC I"), New Mountain Finance SBIC II, L.P. ("SBIC II") and New Mountain Finance SBIC III, L.P. ("SBIC III"), who have received licenses from the U.S. Small Business Administration ("SBA") to operate as small business investment companies ("SBICs") under Section 301(c) of the Small Business Investment Act of 1958, as amended (the "SBIC Act"), and their general partners, New Mountain Finance SBIC G.P., L.L.C. ("SBIC I GP"), New Mountain Finance SBIC II G.P., L.L.C. ("SBIC II GP") and New Mountain Finance SBIC III G.P., L.L.C. ("SBIC III GP"), respectively;

NMF QID NGL Holdings, Inc. ("NMF QID"), NMF YP Holdings, Inc. ("NMF YP"), NMF Permian Holdings, LLC ("NMF Permian"), NMF HB, Inc. ("NMF HB") and NMF Pioneer, Inc. ("NMF Pioneer"), which are treated as corporations for U.S. federal income tax purposes and are intended to facilitate the Company's compliance with the requirements to be treated as a RIC under the Code by holding equity or equity related investments in portfolio companies organized as limited liability companies (or other forms of pass-through entities); the Company consolidates these corporations for accounting purposes but the corporations are not consolidated for U.S. federal income tax purposes and may incur U.S. federal income tax expense as a result of their ownership of the portfolio companies; and

New Mountain Finance Servicing, L.L.C. ("NMF Servicing"), which serves as the administrative agent on certain investment transactions.

New Mountain Net Lease Corporation ("NMNLC") is a majority-owned consolidated subsidiary of the Company, which acquires commercial real estate properties that are subject to "triple net" leases and has elected to be treated, and intends to comply with the requirements to continue to qualify annually, as a real estate investment trust, or REIT, within the meaning of Section 856(a) of the Code.

NMFC is a BDC focused on providing direct lending solutions to U.S. upper middle market companies backed by private equity sponsors. The Company’s investment objective is to generate current income and capital appreciation through the sourcing and origination of senior secured loans and select junior capital positions to growing businesses in defensive industries that offer attractive risk-adjusted returns. The Company’s investment approach leverages the deep sector knowledge and operating resources of New Mountain Capital.

Senior secured loans may include traditional first lien loans or unitranche loans. The Company invests a significant portion of its portfolio in unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first-lien position. Because unitranche loans combine characteristics of senior and subordinated debt, they have risks similar to the risks associated with secured debt and subordinated debt. Certain unitranche loan investments may include “last-out” positions, which generally heighten the risk of loss. In some cases, the Company’s investments may also include equity interests.

NMFC primarily invests in senior secured debt of U.S. sponsor-backed, middle market companies. The Company defines middle market companies as those with annual earnings before interest, taxes, depreciation, and amortization ("EBITDA") of $10 million to $200 million. The Company focuses on defensive growth businesses that generally exhibit the following characteristics: (i) acyclicality, (ii) sustainable secular growth drivers, (iii) niche market dominance and high barriers to competitive entry, (iv) recurring revenue and strong free cash flow, (v) flexible cost structures and (vi) seasoned management teams.

Similar to the Company, the investment objective of each of SBIC I, SBIC II and SBIC III is to generate current income and capital appreciation under the investment criteria used by the Company. However, investments made by SBIC I, SBIC II and SBIC III must be in SBA eligible small businesses.

The Company’s portfolio may be concentrated in a limited number of industries. As of September 30, 2026, the Company’s top five industry concentrations were business services, software, healthcare, investment funds (which includes the Company's investments in its joint ventures) and consumer services.

Note 2. Summary of Significant Accounting Policies

Basis of accounting—The Company’s consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). The Company is an investment company following accounting and reporting guidance in Accounting Standards Codification Topic 946, Financial Services—Investment Companies (“ASC 946”). The Company consolidates its wholly-owned direct and indirect subsidiaries: NMF Holdings, NMF Servicing, SBIC I, SBIC I GP, SBIC II, SBIC II GP, SBIC III, SBIC III GP, NMF QID, NMF YP, NMF Permian, NMF HB and NMF Pioneer and its majority-owned consolidated subsidiary: NMNLC. For majority-owned consolidated subsidiaries, the third-party equity interest is referred to as non-controlling interest. The net income attributable to non-controlling interests for such subsidiaries is presented as “Net increase (decrease) in net assets resulting from operations related to non-controlling interest in New Mountain Net Lease Corporation” in the Company’s Consolidated Statements of Operations. The portion of stockholders' equity that is attributable to non-controlling interests for such subsidiaries is presented as “Non-controlling interest in New Mountain Net Lease Corporation”, a component of total equity, on the Company’s Consolidated Statements of Assets and Liabilities.

The Company’s consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of operations and financial condition for all periods presented. All intercompany transactions have been eliminated. Revenues are recognized when earned and expenses when incurred. The financial results of the Company’s portfolio investments are not consolidated in the financial statements.

The Company’s interim consolidated financial statements are prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Article 6 or 10 of Regulation S-X. Accordingly, the Company’s interim consolidated financial statements do not include all of the information and notes required by GAAP for annual financial statements. In the opinion of management, all adjustments, consisting solely of normal recurring accruals considered necessary for the fair presentation of financial statements for the interim period, have been included. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending December 31, 2026.

Investments—The Company applies fair value accounting in accordance with GAAP. Fair value is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Investments are reflected on the Company’s Consolidated Statements of Assets and Liabilities at fair value, with changes in unrealized gains and losses resulting from changes in fair value reflected in the Company’s Consolidated Statements of Operations as “Net change in unrealized appreciation (depreciation)” and realizations on portfolio investments reflected in the Company’s Consolidated Statements of Operations as “Net realized gains (losses)”.

The Company values its assets on a quarterly basis, or more frequently if required under the 1940 Act. In all cases, the Company’s board of directors is ultimately and solely responsible for determining the fair value of the portfolio investments on a quarterly basis in good faith, including investments that are not publicly traded, those whose market prices are not readily available and any other situation where its portfolio investments require a fair value determination. Security transactions are accounted for on a trade date basis. The Company’s quarterly valuation procedures are set forth in more detail below:

(1)Investments for which market quotations are readily available on an exchange are valued at such market quotations based on the closing price indicated from independent pricing services.

(2)Investments for which indicative prices are obtained from various pricing services and/or brokers or dealers are valued through a multi-step valuation process, as described below, to determine whether the quote(s) obtained is representative of fair value in accordance with GAAP.

a. Bond quotes are obtained through independent pricing services. Internal reviews are performed by the investment professionals of the Investment Adviser to ensure that the quote obtained is representative of fair value in accordance with GAAP and, if so, the quote is used. If the Investment Adviser is unable to sufficiently validate the quote(s) internally and if the investment’s par value or its fair value exceeds the materiality threshold, the investment is valued similarly to those assets with no readily available quotes (see (3) below); and

b. For investments other than bonds, the Company looks at the number of quotes readily available and performs the following procedures:

i. Investments for which two or more quotes are received from a pricing service are valued using the mean of the mean of the bid and ask of the quotes obtained. The Company will evaluate the reasonableness of the quote, and if the quote is determined to not be representative of fair value, the Company will use one or more of the methodologies outlined below to determine fair value; and

ii. Investments for which one quote is received from a pricing service are validated internally. The investment professionals of the Investment Adviser analyze the market quotes obtained using an array of valuation methods (further described below) to validate the fair value. If the Investment Adviser is unable to sufficiently validate the quote internally and if the investment’s par value or its fair value exceeds the materiality threshold, the investment is valued similarly to those assets with no readily available quotes (see (3) below).

(3)Investments for which quotations are not readily available through exchanges, pricing services, brokers, or dealers are valued through a multi-step valuation process:

a. Each portfolio company or investment is initially valued by the investment professionals of the Investment Adviser responsible for the credit monitoring;

b. Preliminary valuation conclusions will then be documented and discussed with the Company’s senior management;

c. If an investment falls into (3) above for four consecutive quarters and if the investment’s par value or its fair value exceeds the materiality threshold, then at least once each fiscal year, the valuation for each portfolio investment for which the Company does not have a readily available market quotation will be reviewed by an independent valuation firm engaged by the Company’s board of directors; and

d. When deemed appropriate by the Company’s management, an independent valuation firm may be engaged to review and value investment(s) of a portfolio company, without any preliminary valuation being performed by the Investment Adviser. The investment professionals of the Investment Adviser will review and validate the value provided.

For investments in revolving credit facilities and delayed draw commitments, the cost basis of the funded investments purchased is offset by any costs/netbacks received for any unfunded portion on the total balance committed. The fair value is also adjusted for the price appreciation or depreciation on the unfunded portion. As a result, the purchase of a commitment not completely funded may result in a negative fair value until it is called and funded.

The values assigned to investments are based upon available information and do not necessarily represent amounts which might ultimately be realized, since such amounts depend on future circumstances and cannot be reasonably determined until the individual positions are liquidated. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period and the fluctuations could be material.

See Note 3. Investments, for further discussion relating to investments.

Derivative instruments and hedging activities—The Company follows the guidance in Accounting Standards Codification Topic 815, Derivatives and Hedging ("ASC 815"), when accounting for derivative instruments and hedging activities. The Company may utilize derivatives to support its overarching risk management objectives. The primary market risk that the Company is exposed to is interest rate risk, which it seeks to mitigate through derivative transactions.

The Company enters into derivative financial instruments to manage interest rate risk, facilitate asset/liability management strategies and manage other exposures. These instruments primarily include interest rate swaps. All derivative financial instruments are recognized as derivative assets at fair value or derivative liabilities at fair value, as applicable.

The Company has entered into an International Swaps and Derivatives Association, Inc. 2002 Master Agreement (together with the Schedule and Credit Support Annex thereto and any transactions thereunder, the "ISDA Master Agreement"), on March 18, 2024, with a derivative counterparty (the “ISDA Counterparty”). The ISDA Master Agreement is a bilateral agreement between the Company and the ISDA Counterparty that governs over-the-counter derivatives, into which the Company enters for hedging purposes. The ISDA Master Agreement provides for, among other things, collateral posting terms and netting provisions in the event of certain specified defaults and/or termination events, including bankruptcy or insolvency of the counterparty. The ISDA Master Agreement also includes termination rights that permit the termination of outstanding transactions by the ISDA Counterparty in the event the Company fails to maintain sufficient asset levels, and by the Company in the event the ISDA Counterparty is downgraded below a specified minimum rating level. The Company minimizes counterparty credit risk by only entering into agreements with counterparties that it believes to be of good standing and by monitoring the financial stability of those counterparties. The collateral terms of the ISDA Master Agreement provide for the bilateral posting of collateral in the form of cash or U.S. government securities for any outstanding exposure under the transactions. In the case of the Company, the agreement provides for the segregation of posted collateral at the Company’s custodian subject to a perfected security interest in favor of the ISDA Counterparty. Upon the close-out of the transactions outstanding under the ISDA Master Agreement following a default, the ISDA Master Agreement provides for a single net payment between the parties equal to the close-out replacement value of the terminated transactions, the right to offset receivables and payables with the same counterparty and/or the right to liquidate collateral.

Interest rate swaps are agreements to exchange interest payments based upon notional amounts and subject the Company to market risk associated with changes in interest rates and changes in interest rate volatility, as well as the credit risk that the counterparty will fail to perform. The Company designates all interest rate swaps as hedging instruments in a qualifying fair value hedge accounting relationship. As a result, the change in fair value of the hedging instrument and hedged item are recorded in "Interest expense" and recognized as components of "Interest and other financing expenses" in the Company’s Consolidated Statements of Operations. The fair value of the interest rate swap is included as a component of "Derivative asset at fair value" or "Derivative liability at fair value" on the Company’s Consolidated Statements of Assets and Liabilities. Derivative assets at fair value and derivative liabilities at fair value, including variation margin as applicable, are included in the "Net change due to hedging activity" line item in the operating section in the Company’s Consolidated Statements of Cash Flows.

The Company elected not to offset derivative assets and liabilities and cash collateral held with the same counterparty where it has a legally enforceable master netting agreement.

Refer to Note 4. Fair Value and Note 7. Borrowings for more information on the Company's derivative instruments and hedging activities.

New Mountain Net Lease Corporation

NMNLC was formed to acquire commercial real estate properties that are subject to "triple net" leases. NMNLC's investments as of September 30, 2026 are disclosed on the Company's Consolidated Schedule of Investments.

On March 30, 2020, an affiliate of the Investment Adviser purchased directly from NMNLC 105,030 shares of NMNLC’s common stock at a price of $107.73 per share, which represented the net asset value per share of NMNLC at the date of purchase, for an aggregate purchase price of approximately $11,315. Immediately thereafter, NMNLC redeemed 105,030 shares of its common stock held by NMFC in exchange for a promissory note with a principal amount of $11,315 and a 7.0% interest rate, which was repaid by NMNLC to NMFC on March 31, 2020. Effective July 1, 2024, NMNLC purchased 63,575 shares of NMNLC's common stock from an affiliate of the Investment Adviser at remaining original cost, a price of $73.39 per share, for an aggregate purchase price of approximately $4,666. Immediately thereafter, NMNLC sold 63,575 shares of its common stock to NMFC at remaining original cost, a price of $73.39 per share, for an aggregate purchase price of approximately $4,666.

Below is certain summarized property information for NMNLC as of September 30, 2026:

Lease · Total · Fair Value as of
Portfolio CompanyTenantExpiration DateLocationSquare FeetSeptember 30, 2026
NM NL Holdings LP / NM GP Holdco LLCVariousVariousVariousVarious$112,365
NM YI, LLCYoung Innovations, Inc.10/31/2039IL / MO2128,784
$121,149

Collateralized agreements or repurchase financings—The Company follows the guidance in Accounting Standards Codification Topic 860, Transfers and Servicing—Secured Borrowing and Collateral, when accounting for transactions involving the purchases of securities under collateralized agreements to resell (resale agreements). These transactions are treated as collateralized financing transactions and are recorded at their contracted resale or repurchase amounts, as specified in the respective agreements. Interest on collateralized agreements is accrued and recognized over the life of the transaction and included in interest income. Upon the counterparty's failure to perform its contractual obligation to repurchase the collateral, the Company's asset no longer represents an interest-bearing collateralized agreement to resell but instead represents a contractual claim in the liquidation proceedings.

The claim arises from a collateralized agreement to resell that was guaranteed by a private hedge fund, PPVA Fund, L.P. The private hedge fund is currently in liquidation under the laws of the Cayman Islands. Pursuant to the terms of the collateralized agreement, the private hedge fund was obligated to repurchase the collateral from the Company at the par value of the collateralized agreement. The private hedge fund has breached its agreement to repurchase the collateral under the collateralized agreement. The default by the private hedge fund did not release the collateral to the Company, and therefore, the Company does not have full rights and title to the collateral.

A claim has been filed with the Cayman Islands joint official liquidators to resolve this matter. The joint official liquidators have recognized the Company’s contractual rights under the collateralized agreement. The Company continues to exercise its rights under the collateralized agreement and continues to monitor the liquidation process of the private hedge fund.

As of September 30, 2026, the Company heldone claim related to the collateralized agreement to resell with a cost basis of $30,000 and a fair value of $5,700. As of December 31, 2025, the Company heldone collateralized agreement to resell with a cost basis of $30,000 and a fair value of $13,500.

Cash and cash equivalents—Cash and cash equivalents include cash and short-term, highly liquid investments. The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near maturity that there is insignificant risk of changes in value. These securities have original maturities of three months or less. The Company didnot hold any cash equivalents as of September 30, 2026 and December 31, 2025. The cash deposits are FDIC insured up to $250 per ownership category, per institution.

Revenue recognition

Sales and paydowns of investments: Realized gains and losses on investments are determined on the specific identification method.

Interest and dividend income: Interest income, including amortization of premium and discount using the effective interest method, is recorded on the accrual basis and periodically assessed for collectibility. Interest income also includes interest earned from cash on hand. Upon the prepayment of a loan or debt security, any prepayment penalties are recorded as part of interest income. The Company has loans and certain preferred equity investments in the portfolio that contain a payment-in-kind (“PIK”) interest or dividend provision. PIK interest and dividends are accrued and recorded as income at the contractual rates, if deemed collectible. The PIK interest and dividends are added to the principal or share balances on the capitalization dates and are generally due at maturity or when redeemed by the issuer. For the three and nine months ended September 30, 2026, the Company recognized PIK interest from investments of $6,626 and $17,178, respectively, and non-cash dividends from investments of $5,179 and $15,382, respectively. For the three and nine months ended September 30, 2025, the Company recognized PIK interest from investments of $7,605 and $22,081, respectively, and non-cash dividends from investments of $7,255 and $22,085, respectively.

Dividend income on common equity is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. Dividend income on preferred securities is recorded as dividend income on an accrual basis to the extent that such amounts are deemed collectible.

Non-accrual income: Investments are placed on non-accrual status when principal or interest payments are past due for 30 days or more and when there is reasonable doubt that principal or interest will be collected. Accrued cash and un-capitalized PIK interest or dividends are generally reversed when an investment is placed on non-accrual status. Previously capitalized PIK interest or dividends are not reversed when an investment is placed on non-accrual status. Interest or dividend payments received on non-accrual investments may be recognized as income or applied to principal depending upon management’s judgment of the ultimate collectibility. Non-accrual investments are restored to accrual status when past due principal and interest are paid and, in management’s judgment, are likely to remain current.

Other income: Other income represents delayed compensation, consent or amendment fees, revolver fees, structuring fees, upfront fees and other miscellaneous fees received and is typically non-recurring in nature. Delayed compensation is income earned from counterparties on trades that do not settle within a set number of business days after the trade date. Other income may also include fees from bridge loans. The Company may from time to time enter into bridge financing commitments, an obligation to provide interim financing to a counterparty until permanent credit can be obtained. These commitments are short-term in nature and may expire unfunded. A fee is received by the Company for providing such commitments. Structuring fees and upfront fees are recognized as income when earned, usually when paid at the closing of the investment, and are non-refundable.

Interest and other financing expenses—Interest and other financing fees are recorded on an accrual basis by the Company. See Note 7. Borrowings, for details.

Deferred financing costs—The deferred financing costs of the Company consist of capitalized expenses related to the origination and amending of the Company’s borrowings. The Company amortizes these costs into expense over the stated life of the related borrowing. See Note 7. Borrowings, for details.

Deferred offering costs—The Company's deferred offering costs consist of fees and expenses incurred in connection with equity offerings and the filing of shelf registration statements. Upon the issuance of shares, offering costs are charged as a direct reduction to net assets. Deferred offering costs are included in other assets on the Company's Consolidated Statements of Assets and Liabilities.

Income taxes—The Company has elected to be treated, and intends to comply with the requirements to qualify annually, as a RIC under Subchapter M of the Code. As a RIC, the Company is not subject to U.S. federal income tax on the portion of taxable income and gains timely distributed to its stockholders.

To continue to qualify and be subject to tax treatment as a RIC, the Company is required to meet certain income and asset diversification tests in addition to timely distributing at least 90.0% of its investment company taxable income, as defined by the Code. Since U.S. federal income tax regulations differ from GAAP, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes.

Differences between taxable income and the results of operations for financial reporting purposes may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their tax character. Differences in classification may also result from the treatment of short-term gains as ordinary income for U.S. federal income tax purposes.

For U.S. federal income tax purposes, distributions paid to stockholders of the Company are reported as ordinary income, return of capital, long term capital gains or a combination thereof.

The Company will be subject to a 4.0% nondeductible U.S. federal excise tax on certain undistributed income unless the Company distributes, in a timely manner as required by the Code, an amount at least equal to the sum of (1) 98.0% of its respective net ordinary income earned for the calendar year and (2) 98.2% of its respective capital gain net income for the one-year period ending October 31 in the calendar year.

Certain consolidated subsidiaries of the Company are subject to U.S. federal and state income taxes. These taxable entities are not consolidated for U.S. federal income tax purposes and may generate income tax liabilities or assets from permanent and temporary differences in the recognition of items for financial reporting and U.S. federal income tax purposes.

The following table summarizes the current income tax expense, deferred income tax provision and total income tax provision, for the three and nine months ended September 30, 2026 and September 30, 2025:

Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Current income tax expense$—$29$23$18
Deferred income tax provision168252268
Total income tax provision$168$54$45$86

As of September 30, 2026 and December 31, 2025, the Company had $1,838 and $1,819, respectively, of deferred tax liabilities, primarily relating to deferred taxes attributable to certain differences between the computation of income for U.S. federal income tax purposes as compared to GAAP.

Based on its analysis, the Company has determined that there were no uncertain income tax positions that do not meet the more likely than not threshold as defined by Accounting Standards Codification Topic 740, Income Taxes("ASC 740") through December 31, 2025. The 2022 through 2025 tax years remain subject to examination by the U.S. federal, state, and local tax authorities.

Distributions—Distributions to common stockholders of the Company are recorded on the record date as set by the board of directors. The Company intends to make distributions to its stockholders that will be sufficient to enable the Company to maintain its status as a RIC. The Company intends to distribute approximately all of its net investment income (see Note 5. Agreements, for details) on a quarterly basis and substantially all of its taxable income on an annual basis, except that the Company may retain certain net capital gains for reinvestment.

The Company has adopted a dividend reinvestment plan that provides for reinvestment of any distributions declared on behalf of its stockholders, unless a stockholder elects to receive cash.

The Company applies the following in implementing the dividend reinvestment plan. If the price at which newly issued shares are to be credited to stockholders' accounts is equal to or greater than 110.0% of the last determined net asset value of the shares, the Company will use only newly issued shares to implement its dividend reinvestment plan. Under such circumstances, the number of shares to be issued to a stockholder is determined by dividing the total dollar amount of the distribution payable to such stockholder by the market price per share of the Company's common stock on NASDAQ Global Select Market ("NASDAQ") on the distribution payment date. Market price per share on that date will be the closing price for such shares on NASDAQ or, if no sale is reported for such day, the average of their electronically reported bid and ask prices.

If the price at which newly issued shares are to be credited to stockholders' accounts is less than 110.0% of the last determined net asset value of the shares, the Company will either issue new shares or instruct the plan administrator to purchase shares in the open market to satisfy the additional shares required. Shares purchased in open market transactions by the plan administrator will be allocated to a stockholder based on the average purchase price, excluding any brokerage charges or other charges, of all shares of common stock purchased in the open market. The number of shares of the Company's common stock to be outstanding after giving effect to payment of the distribution cannot be established until the value per share at which additional shares will be issued has been determined and elections of the Company's stockholders have been tabulated.

Stock repurchase program—On February 4, 2016, the Company's board of directors authorized a program for the purpose of repurchasing up to $50,000 worth of the Company's common stock (the "Old Repurchase Program"). The Old Repurchase Program terminated on October 8, 2025 upon the repurchase of $50,000 of the Company's common stock. On October 23, 2025, the Company's board of directors authorized a new program for the purpose of repurchasing up to $100,000 worth of the Company's common stock (the "Repurchase Program"). On April 28, 2026, the Company's board of directors authorized the repurchase of up to an additional $50,000 of the Company's common stock under the Repurchase Program. Giving effect to the increase, the Repurchase Program authorizes the Company to repurchase up to $150,000 worth of its common stock. On October 20, 2026, the Company's board of directors extended the Company's Repurchase Program and the Company expects the Repurchase Program to be in place until the earlier of December 31, 2027 or until $150,000 worth of its common stock has been repurchased.

Under the Old Repurchase Program and the Repurchase Program, the Company is permitted, but is not obligated, to repurchase its outstanding shares of common stock in the open market from time to time provided that it complies with the Company's code of ethics and the guidelines specified in Rule 10b-18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including certain price, market volume and timing constraints. In addition, any repurchases are conducted in accordance with the 1940 Act.

For the three months ended September 30, 2026, the Company didnot repurchase any shares of common stock. For the nine months ended September 30, 2026, the Company repurchased a total of 8,185,998 shares of the Company's common stock in the open market for $65,563, including commissions paid. During the three and nine months ended September 30, 2025, the Company repurchased 2,737,377 and 3,662,593 shares, respectively, of the Company's common stock in the open market for $27,611 and $37,253, respectively, including commissions paid. Since the inception of the Repurchase Program through September 30, 2026, the Company repurchased $70,463 worth of its common stock under the Repurchase Program.

Earnings (loss) per share—The Company's earnings (loss) per share ("EPS") amounts have been computed based on the weighted-average number of shares of common stock outstanding for the period. Basic EPS is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average number of shares of common stock outstanding during the period of computation. Diluted EPS is computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average number of shares of common stock assuming all potential shares had been issued, and its related net impact to net assets accounted for, and the additional shares of common stock were dilutive. Diluted EPS reflects the potential dilution, using the if-converted method for convertible debt, which could occur if all potentially dilutive securities were exercised.

Foreign securities—The accounting records of the Company are maintained in U.S. dollars. Investment securities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies on the date of valuation. Purchases and sales of investment securities and income and expense items denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies on the respective dates of the transactions. The Company isolates that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations are included with "Net change in unrealized appreciation (depreciation)" and "Net realized gains (losses)" in the Company's Consolidated Statements of Operations.

Investments denominated in foreign currencies may be negatively affected by movements in the rate of exchange between the U.S. dollar and such foreign currencies. This movement is beyond the control of the Company and cannot be predicted.

Use of estimates—The preparation of the Company's consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the Company's consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Changes in the economic environment, financial markets, and other metrics used in determining these estimates could cause actual results to differ from the estimates used, and the differences could be material.

Note 3. Investments

At September 30, 2026, the Company's investments consisted of the following:

Investment Cost and Fair Value by Type

CostFair Value
First lien$1,500,316$1,430,905
Second lien83,84968,064
Subordinated101,477101,722
Structured Finance Obligations3,2323,217
Equity and other765,116656,054
Total investments$2,453,990$2,259,962

Investment Cost and Fair Value by Industry

CostFair Value
Business Services$521,261$476,150
Software405,342376,858
Healthcare394,706363,588
Investment Funds (includes investments in joint ventures)275,632260,701
Consumer Services145,272140,394
Financial Services & Technology131,318136,281
Net Lease80,336121,149
Education200,836118,364
Distribution & Logistics114,058100,692
Packaging89,95184,036
Energy80,33269,283
Consumer Products14,94612,466
Total investments$2,453,990$2,259,962

At December 31, 2025, the Company’s investments consisted of the following:

Investment Cost and Fair Value by Type

CostFair Value
First lien$1,854,022$1,818,215
Second lien104,89091,179
Subordinated128,705121,487
Structured Finance Obligations3,2323,277
Equity and other821,266707,855
Total investments$2,912,115$2,742,013

Investment Cost and Fair Value by Industry

CostFair Value
Software$533,638$526,440
Business Services573,549516,701
Healthcare517,598463,591
Investment Funds (includes investments in joint ventures)275,632275,677
Consumer Services193,415192,842
Financial Services & Technology165,745172,215
Distribution & Logistics162,382158,599
Education195,960118,507
Net Lease81,370115,127
Packaging76,05275,324
Energy75,77165,833
Food & Beverage21,19321,177
Business Products15,89716,026
Consumer Products14,28314,283
Specialty Chemicals & Materials9,6309,671
Total investments$2,912,115$2,742,013

As of September 30, 2026, the Company's aggregate principal amount of its subordinated position and first lien term loans in American Achievement Corporation ("AAC") was $5,230 and $31,406, respectively. During the first quarter of 2021, the Company placed an aggregate principal amount of $5,230 of its subordinated position on non-accrual status. During the third quarter of 2021, the Company placed an initial aggregate principal amount of $13,479 of its first lien term loans on non-accrual status. During the third quarter of 2023, the Company placed the remaining aggregate principal amount of $17,927 of its first lien term loans on non-accrual status. For the three and nine months ended September 30, 2026, the Company's positions in AAC on non-accrual status had total unearned interest income of $1,478 and $4,261, respectively.

During the second quarter of 2024, the Company placed its junior Series B preferred shares in Eclipse Topco Holdings, Inc. (fka Transcendia Holdings, Inc.) ("Transcendia") on non-accrual status. For the three and nine months ended September 30, 2026, the Company's junior Series B preferred shares in Transcendia had total unearned income of $132 and $374, respectively.

During the first quarter of 2026, the Company placed its first lien positions in Convey Health Solutions, Inc. ("Convey") on non-accrual status. For the three and nine months ended September 30, 2026, the Company's first lien positions in Convey had total unearned income of $388 and $1,075, respectively.

During the second quarter of 2026, the Company placed its Series A preferred shares in Symplr Software Intermediate Holdings, Inc. ("Symplr") on non-accrual status. For the three and nine months ended September 30, 2026, the Company's Series A preferred shares in Symplr had total unearned income of $738 and $1,447, respectively.

During the third quarter of 2026, the Company placed its first lien term loan in LogRhythm, Inc. ("LogRhythm") on non-accrual status. For the three and nine months ended September 30, 2026, the Company's first lien term loan in LogRhythm had total unearned income of $245 and $245, respectively.

For a discussion of the Company's unfunded commitments, see Note 9. Commitments and Contingencies.

PPVA Black Elk (Equity) LLC

On May 3, 2013, the Company entered into a collateralized securities purchase and put agreement (the “SPP Agreement”) with a private hedge fund. Under the SPP Agreement, the Company purchased twenty million Class E Preferred Units of Black Elk Energy Offshore Operations, LLC (“Black Elk”) for $20,000 with a corresponding obligation of the private hedge fund, PPVA Black Elk (Equity) LLC, to repurchase the preferred units for $20,000 plus other amounts due under the SPP Agreement. The majority owner of Black Elk was the private hedge fund. In August 2014, the Company received a payment of $20,540, the full amount due under the SPP Agreement.

In August 2017, a trustee (the “Trustee”) for Black Elk informed the Company that the Trustee intended to assert a fraudulent conveyance claim (the “Claim”) against the Company and one of its affiliates seeking the return of the $20,540 repayment. Black Elk filed a Chapter 11 bankruptcy petition pursuant to the U.S. Bankruptcy Code in August 2015. The Trustee alleged that individuals affiliated with the private hedge fund conspired with Black Elk and others to improperly use proceeds from the sale of certain Black Elk assets to repay, in August 2014, the private hedge fund’s obligation to the Company under the SPP Agreement. The Company was unaware of these claims at the time the repayment was received. The private hedge fund is currently in liquidation under the laws of the Cayman Islands.

On December 22, 2017, the Company settled the Trustee’s $20,540 Claim for $16,000 and filed a claim with the Cayman Islands joint official liquidators of the private hedge fund for $16,000 that is owed to the Company under the SPP Agreement. As a result of the settlement and the counterparty's failure to satisfy its contractual obligations, the Company's rights under the SPP Agreement have been converted into a contractual claim being pursued through the Cayman Islands liquidation proceedings. Accordingly, the Company no longer classifies the asset as a collateralized securities purchase and put agreement and instead classifies the position as a claim. During the year ended December 31, 2018, the Company received a $1,500 payment from its insurance carrier in respect to the settlement. As of September 30, 2026, the claim had a cost basis of $14,500 and a fair value of $2,755. As of December 31, 2025, the SPP Agreement had a cost basis of $14,500 and a fair value of $6,525.

NMFC Senior Loan Program III LLC

NMFC Senior Loan Program III LLC ("SLP III") was formed as a Delaware limited liability company and commenced operations on April 25, 2018. SLP III is structured as a private joint venture investment fund between the Company and SkyKnight Income II, LLC (“SkyKnight II”) and operates under a limited liability company agreement (the "SLP III Agreement"). The purpose of the joint venture is to invest primarily in senior secured loans issued by portfolio companies within the Company's core industry verticals. These investments are typically broadly syndicated first lien loans. All investment decisions must be unanimously approved by the board of managers of SLP III, which has equal representation from the Company and SkyKnight II. SLP III initially had afive-year investment period and will continue in existence until August 7, 2030. On August 6, 2025, the investment period was extended until August 7, 2028. The investment period may be extended for up toone additional year subject to certain conditions.

SLP III is capitalized with equity contributions which are called from its members, on a pro-rata basis based on their equity commitments, as transactions are completed. Any decision by SLP III to call down on capital commitments requires approval by the board of managers of SLP III. As of September 30, 2026, the Company and SkyKnight II have committed and contributed $160,000 and $40,000, respectively, of equity to SLP III. The Company’s investment in SLP III is disclosed on the Company’s Consolidated Schedule of Investments as of September 30, 2026 and December 31, 2025.

On May 2, 2018, SLP III entered into its revolving credit facility with Citibank, N.A. As of the amendment on August 6, 2025, the maturity date of SLP III's revolving credit facility was extended to August 7, 2030, and the reinvestment period was extended to August 7, 2028.

On August 6, 2025, SLP III entered into an amendment to add a subordinate lender (“Class B lenders”) to the existing lender (“Class A lenders”). As of the amendment on August 6, 2025, SLP III's revolving credit facility has a maximum borrowing capacity of $941,000 of which $830,000 of the facility amount is attributed to Class A lenders and $111,000 is attributed to Class B lenders. Prior to the amendment on August 6, 2025, SLP III's revolving credit facility had a maximum borrowing capacity of $600,000, with the full amount attributable to one class of lenders. As of the amendment on August 6, 2025, during the reinvestment period, Class A advances bear interest at a rate of the Secured Overnight Financing Rate ("SOFR") plus 1.50%, and after the reinvestment period Class A advances will bear interest at a rate of SOFR plus 1.80% and Class B advances bear interest at a rate of the SOFR plus 4.75%, and after the reinvestment period Class B advances will bear interest at a rate of the SOFR plus 5.05%. From July 3, 2024 to August 6, 2025, during the reinvestment period, the credit facility bore interest at a rate of SOFR plus 1.65%, and after the reinvestment period it bore interest at a rate of SOFR plus 1.95%.

As of September 30, 2026 and December 31, 2025, SLP III had total investments with an aggregate fair value of approximately $872,188 and $941,427, respectively, and debt outstanding under its credit facility of $758,200 and $672,700, respectively. Additionally, as of September 30, 2026 and December 31, 2025, SLP III had unfunded commitments in the form of delayed draws of $2,593 and $6,867, respectively.

During the first quarter of 2026, SLP III placed its first lien position in Convey on non-accrual status. As of September 30, 2026, SLP III's first lien position in Convey had total unearned income of $205 and $623, respectively, for the three and nine months then ended.

Below is a summary of SLP III's portfolio, along with a listing of the individual investments in SLP III's portfolio as of September 30, 2026 and December 31, 2025:

September 30, 2026December 31, 2025
First lien investments (1)$930,815$971,559
Weighted average interest rate on first lien investments (2)7.68%8.36%
Number of portfolio companies in SLP III105105
Largest portfolio company investment (1)$19,316$19,791
Total of five largest portfolio company investments (1)$88,167$93,239

The following table is a listing of the individual investments in SLP III's portfolio as of September 30, 2026:

Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal AmountCostFair Value (2)
Funded Investments - First lien
Accelya Lux Finco S.a r.l.Business ServicesSOFR(Q)5.25%9.32%10/2032$16,363$16,068$14,809
ADMI Corp. (aka Aspen Dental)HealthcareSOFR(M)3.75%7.77%12/20272,3092,3062,188
Allium Buyer LLCBusiness ServicesSOFR(Q)4.25%8.30%09/20319,4679,3259,502
AmSpec Parent, LLCEnergySOFR(Q)3.00%7.07%12/20319,4229,4079,457
Ardonagh Midco 3 LimitedBusiness ServicesSOFR(S)3.00%6.84%02/20311,9751,9681,961
Asurion, LLCBusiness ServicesSOFR(Q)3.75%7.57%02/20334,4114,3904,097
athenahealth Group Inc.HealthcareSOFR(M)3.25%7.15%02/20323,0783,0783,078
BCPE Empire Holdings, Inc.Distribution & LogisticsSOFR(M)3.25%7.15%12/203010,88910,84110,548
BCPE Empire Holdings, Inc.Distribution & LogisticsSOFR(M)3.50%7.40%12/20327,1467,0486,894
Bella Holding Company, LLCHealthcareSOFR(M)3.25%7.15%06/20337,6837,6097,701
Berlin Packaging L.L.C.PackagingSOFR(Q)3.25%7.22%06/20318,6698,6688,616
BIFM CA Buyer Inc.Business ServicesSOFR(M)3.25%7.15%05/20288,9818,9698,989
Cardinal Parent, Inc.Financial Services & TechnologySOFR(Q)4.50%8.72%11/202711,53511,46610,375
Chrysaor Bidco S.a r.l.Financial Services & TechnologySOFR(Q)3.00%6.76%10/20312,0992,0992,109
Citrin Cooperman Advisors LLCFinancial Services & TechnologySOFR(Q)3.00%7.07%04/20324,8384,8144,786
Cleanova US Holdings LLCBusiness ProductsSOFR(Q)4.75%8.61%06/203217,36717,21917,378
Cloudera, Inc.SoftwareSOFR(M)3.75%7.75%10/202813,95213,83613,039
Clydesdale Acquisition Holdings, Inc.PackagingSOFR(M)3.25%7.15%04/20329,2669,2629,107
Cohnreznick Advisory LLCFinancial Services & TechnologySOFR(Q)3.25%7.32%03/20327,1627,1427,114
Confluent Health, LLCHealthcareSOFR(M)4.00%8.02%11/20284,5674,5584,266
ConnectWise, LLCSoftwareSOFR(Q)3.50%7.84%09/202811,42211,41511,240
Convey Health Solutions, Inc. (3)HealthcareSOFR(Q)1.31% + 2.63%/PIK8.11%07/20299,0588,706978
CoreLogic, Inc. (fka First American Corporation, The)Business ServicesSOFR(M)4.25%8.15%07/20319,0008,8208,539
Cornerstone OnDemand, Inc.SoftwareSOFR(M)3.75%7.77%10/20282,5132,5091,594
Cub Financing Intermediate, LLCFinancial Services & TechnologySOFR(Q)4.25%8.33%08/2033925916931
CVET Midco 2, L.P.Distribution & LogisticsSOFR(Q)5.00%9.07%10/20299,6319,3889,375
Dayforce Bidco, LLCSoftwareSOFR(Q)3.00%6.82%02/20335,5355,3735,337
Dealer Tire Financial, LLCDistribution & LogisticsSOFR(M)3.00%6.90%07/203111,34911,30711,259
DG Investment Intermediate Holdings 2, Inc.Business ServicesSOFR(M)3.00%6.90%07/203211,92811,89211,958
Discovery Purchaser CorporationSpecialty Chemicals & MaterialsSOFR(Q)3.75%7.48%10/202910,1259,90910,102
EAB Global, Inc.EducationSOFR(M)3.00%6.90%08/203010,0069,8348,916
Eagle Parent Corp.Business ServicesSOFR(Q)4.25%8.32%04/202913,75813,63513,851
Eisner Advisory Group LLCFinancial Services & TechnologySOFR(M)4.00%7.90%02/203111,25711,16811,252
Embecta Corp.HealthcareSOFR(Q)3.00%7.07%03/20293,7533,7603,184
Finastra USA, Inc.Financial Services & TechnologySOFR(S)4.00%7.75%09/203212,31112,20811,905
Flash Charm, Inc.SoftwareSOFR(Q)3.50%7.31%03/20286,5016,4995,742
FNZ Group Entities LimitedFinancial Services & TechnologySOFR(Q)5.00%8.76%11/203110,1019,9406,530
Foundational Education Group, Inc.EducationSOFR(Q)4.25%8.33%08/202813,95313,89613,032
Groundworks, LLCBusiness ServicesSOFR(M)3.50%7.40%03/203110,0249,99710,038
Heartland Dental, LLCHealthcareSOFR(M)3.00%6.82%08/20323,7183,7133,715
Help/Systems Holdings, Inc.SoftwareSOFR(Q)6.00%9.86%05/202911,05711,0418,379
HIG Finance 2 LimitedFinancial Services & TechnologySOFR(M)2.75%6.65%02/20316,4516,2796,225
HIG Operations Holdings, Inc.Business ServicesSOFR(M)4.50%8.40%06/203111,76011,72211,760
Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal AmountCostFair Value (2)
HIG Operations Holdings, Inc.Business ServicesSOFR(M)4.50%8.40%06/2031$1,115$1,110$1,115
Houghton Mifflin Harcourt CompanyEducationSOFR(M)5.25%9.25%04/20297,9247,7925,398
HP PHRG Borrower, LLCConsumer ServicesSOFR(Q)4.00%8.07%02/203216,51616,42016,449
Inizio Group LimitedHealthcareSOFR(Q)4.25%8.42%08/202812,74712,69012,476
Jones DesLauriers Insurance Management Inc.Business ServicesSOFR(Q)3.00%6.82%02/20336,4616,3576,386
Kaseya Inc.SoftwareSOFR(Q)3.25%7.07%03/203212,72312,70210,651
KnowBe4, Inc.EducationSOFR(Q)3.75%7.57%07/20327,1197,1185,047
LI Group Holdings, Inc.EducationSOFR(M)3.50%7.52%03/20282,9982,9962,990
LSCS Holdings, Inc.HealthcareSOFR(Q)4.50%8.57%03/203214,75114,67114,668
LTR Intermediate Holdings, Inc.Specialty Chemicals & MaterialsSOFR(M)3.75%7.64%12/20327,8787,8427,907
Marcel Bidco LLC (Marcel Bidco GmbH)SoftwareSOFR(M)3.00%6.87%11/20302,0342,0191,986
Mavis Tire Express Services Topco, Corp.RetailSOFR(Q)3.25%6.92%05/203313,93713,86813,823
MED ParentCo, LPHealthcareSOFR(M)3.00%6.90%04/20316,5126,4946,508
Michael Baker International, LLCBusiness ServicesSOFR(Q)4.00%7.82%12/20285,4925,4925,499
Michael Baker International, LLCBusiness ServicesSOFR(M)4.50%8.40%12/20282,1632,1122,166
Neon Maple Purchaser Inc.Financial Services & TechnologySOFR(M)2.50%6.40%11/20315,7175,7215,570
Nexus Buyer LLCFinancial Services & TechnologySOFR(M)4.00%7.90%07/203113,90613,84413,779
Nielsen Consumer, Inc.Business ServicesSOFR(M)2.25%6.15%10/20305,7285,3995,711
Oceankey (U.S.) II Corp.SoftwareSOFR(M)3.50%7.50%12/202813,90413,90813,757
OCM System One Buyer CTB, LLC (Sentinel Purchaser II Holdco, LLC)Business ServicesSOFR(M)3.75%7.65%08/20337,5747,5367,564
Orbit Private Holdings I LtdFinancial Services & TechnologySOFR(S)3.75%7.60%12/20319,3159,2849,332
Osaic Holdings, Inc.Financial Services & TechnologySOFR(Q)2.50%6.57%07/20325,5475,5475,504
Osmose Utilities Services, Inc.Specialty Chemicals & MaterialsSOFR(M)3.25%7.27%06/202813,84213,47113,826
OSTTRA Group LtdFinancial Services & TechnologySOFR(Q)3.00%6.75%10/203210,27710,26710,290
Outcomes Group Holdings, Inc.HealthcareSOFR(Q)3.00%6.76%05/20314,0574,0454,081
OVG Business Services, LLCBusiness ServicesSOFR(M)3.00%6.90%06/20312,7482,7362,763
Paradigm Parent, LLCDistribution & LogisticsSOFR(Q)4.50%8.57%04/2032625556584
Pearls (Netherlands) Bidco B.V.Specialty Chemicals & MaterialsSOFR(Q)3.25%7.07%02/20291,2021,1621,141
Perforce Software, Inc.SoftwareSOFR(M)4.75%8.65%03/20314,0043,9922,055
Physician Partners, LLCHealthcareSOFR(Q)6.00%10.07%12/20293,3363,2333,385
Physician Partners, LLCHealthcareSOFR(Q)4.00%8.22%12/20292,8402,8282,746
Pioneer AcquisitionCo, LLCBusiness ServicesSOFR(Q)2.50%6.57%10/20324,7074,6964,683
Planview Parent, Inc.SoftwareSOFR(Q)3.50%7.57%12/202713,40113,33511,223
Pretium PKG Holdings, Inc.PackagingSOFR(Q)5.25%8.98%03/20315,6005,5745,556
Project Alpha Intermediate Holding, Inc.SoftwareSOFR(Q)3.25%7.32%10/203013,40313,2299,473
Pushpay USA Inc.Financial Services & TechnologySOFR(Q)3.75%7.57%08/203113,79813,78112,510
Quartz AcquireCo, LLCBusiness ServicesSOFR(Q)2.25%6.32%06/20302,6192,6102,280
RealPage, Inc.SoftwareSOFR(Q)3.00%7.34%04/20285,5095,5005,444
RealPage, Inc.SoftwareSOFR(Q)3.75%7.82%04/20287,4227,3427,351
Rithum Holdings, Inc. (fka CommerceHub, Inc.)SoftwareSOFR(Q)4.75%8.82%07/203215,62615,53514,743
RLG Holdings, LLCPackagingSOFR(Q)4.25%8.33%07/20287,0506,8623,211
RxB Holdings, Inc.HealthcareSOFR(M)5.00%8.90%12/20305,0925,0025,098
Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal AmountCostFair Value (2)
Secretariat Advisors LLCBusiness ServicesSOFR(Q)4.00%8.07%02/2032$9,717$9,686$9,422
Secure Acquisition, Inc.PackagingSOFR(M)3.75%7.65%12/20283,8193,8183,831
SonarSource Financing, LLCSoftwareSOFR(Q)4.50%8.23%12/203011,05410,90910,778
Sovos Compliance, LLC (fka Taxware, LLC)SoftwareSOFR(M)3.25%7.15%08/202911,03610,94510,746
Spring Education Group, Inc.EducationSOFR(Q)3.25%7.32%10/203013,06212,96613,074
STATS Intermediate Holdings, LLCBusiness ServicesSOFR(Q)7.00%10.74%04/20309,9509,6029,863
Storable, Inc.SoftwareSOFR(M)3.25%7.15%04/20319,8829,8118,562
Summit Acquisition Inc.Business ServicesSOFR(M)3.50%7.40%10/20316,4216,3976,443
Sword Purchaser, LLCPackagingSOFR(M)4.00%7.90%04/20334,4604,2374,457
Symplr Software, Inc.HealthcareSOFR(Q)4.50%8.42%12/202715,12015,09112,676
Team.blue Finco SARLSoftwareSOFR(Q)3.25%7.32%07/20325,9855,9915,873
Tegra118 Wealth Solutions, Inc.Financial Services & TechnologySOFR(Q)4.00%7.82%01/203311,72711,64111,797
Tempo Acquisition, LLCBusiness ServicesSOFR(M)1.75%5.65%08/20284,0323,4203,209
Therapy Brands Holdings LLCHealthcareSOFR(Q)4.00%8.03%05/20283,9433,9383,943
Thermostat Purchaser III, Inc.Business ServicesSOFR(Q)4.25%8.32%08/202813,40213,39813,214
Tricorbraun Holdings, Inc.PackagingSOFR(M)3.25%7.15%03/203111,03511,00110,582
TruGreen Limited PartnershipConsumer ServicesSOFR(M)4.00%8.00%11/20275,3165,0875,192
UKG Inc.SoftwareSOFR(Q)2.25%6.07%02/20315,2695,1835,121
US Fertility Enterprises, LLCHealthcareSOFR(Q)3.00%7.07%12/20327,4547,4207,480
Valcour Packaging, LLCPackagingSOFR(M)5.25%9.15%10/202811,19511,26711,297
Valcour Packaging, LLCPackagingSOFR(M)3.75%7.76%10/20283,2123,2122,559
Viant Medical Holdings, Inc.HealthcareSOFR(M)4.00%7.90%10/203111,36711,34911,184
VSTG Intermediate Holdings, Inc.Business ServicesSOFR(Q)3.75%7.82%07/202911,10211,09510,928
Xplor T1, LLCFinancial Services & TechnologySOFR(Q)3.25%7.05%12/203216,93316,86316,382
Zelis Cost Management Buyer, Inc.HealthcareSOFR(M)3.25%7.15%11/203119,31619,31819,249
Zest Acquisition Corp.HealthcareSOFR(M)6.00%9.90%02/20315,8795,7915,791
Total Funded Investments$928,222$920,114$872,238
Unfunded Investments - First lien
Citrin Cooperman Advisors LLCFinancial Services & Technology———04/2027$1,022$(10)$(15)
Secretariat Advisors LLCBusiness Services———02/20271,1881(36)
US Fertility Enterprises, LLCHealthcare———12/2027383(2)1
Total Unfunded Investments$2,593$(11)$(50)
Total Investments$930,815$920,103$872,188

(1)All interest is payable in cash unless otherwise indicated. All of the variable rate debt investments bear interest at a rate that may be determined by reference to the Secured Overnight Financing Rate (SOFR). For each investment, the current interest rate provided reflects the rate in effect as of September 30, 2026.

(2)Represents the fair value in accordance with Accounting Standards Codification Topic 820, Fair Value Measurement and Disclosures ("ASC 820"). The Company's board of managers does not determine the fair value of the investments held by SLP III.

(3)Investment is on non-accrual status as of September 30, 2026.

The following table is a listing of the individual investments in SLP III's portfolio as of December 31, 2025:

Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal Amount or Par ValueCostFair Value (2)
Funded Investments - First lien
Accelya Lux Finco S.a r.l.Business ServicesSOFR(Q)5.25%8.92%10/2032$16,487$16,162$16,435
ADMI Corp. (aka Aspen Dental)HealthcareSOFR(M)3.75%7.58%12/20272,3272,3232,214
AmSpec Parent, LLCEnergySOFR(Q)3.50%7.17%12/20319,4939,4789,540
Ardonagh Midco 3 LimitedBusiness ServicesSOFR(S)2.75%6.92%02/20311,9901,9821,990
Asurion, LLCBusiness ServicesSOFR(M)4.25%8.07%08/202813,00012,93113,039
Asurion, LLCBusiness ServicesSOFR(M)4.25%7.97%09/20303,6183,5173,621
Asurion, LLCBusiness ServicesSOFR(M)4.25%7.97%09/20301,9851,9581,988
athenahealth Group Inc.HealthcareSOFR(M)2.75%6.47%02/202912,11712,00512,155
Bach Finance LimitedEducationSOFR(Q)2.75%6.57%01/20322,1072,1032,117
BCPE Empire Holdings, Inc.Distribution & LogisticsSOFR(M)3.25%6.97%12/203011,82111,76111,718
Bella Holding Company, LLCHealthcareSOFR(M)3.00%6.72%05/20287,7227,7077,760
Berlin Packaging L.L.C.PackagingSOFR(M)3.25%7.11%06/20318,7358,7348,765
BIFM CA Buyer Inc.Business ServicesSOFR(M)3.25%6.97%05/20289,0499,0329,123
Boxer Parent Company Inc.SoftwareSOFR(Q)3.00%6.82%07/20317,4167,4007,405
BradyPLUS Holdings, LLCDistribution & LogisticsSOFR(Q)3.50%7.15%12/20327,1827,0757,118
BW Holding, Inc.PackagingSOFR(Q)6.50%10.34%12/2030603597616
Capstone Borrower, Inc.SoftwareSOFR(Q)2.75%6.40%06/20303,1243,1093,126
Cardinal Parent, Inc.Financial Services & TechnologySOFR(Q)4.50%8.32%11/202711,62611,51311,384
Chrysaor Bidco S.a r.l.Financial Services & TechnologySOFR(Q)3.25%7.14%10/20312,1152,1152,133
Citrin Cooperman Advisors LLCFinancial Services & TechnologySOFR(Q)3.00%6.67%04/20326,7196,7116,747
Cleanova US Holdings LLCBusiness ProductsSOFR(Q)4.75%8.48%06/203218,74118,56518,741
Cloudera, Inc.SoftwareSOFR(M)3.75%7.57%10/202814,06213,90413,511
Clydesdale Acquisition Holdings, Inc.PackagingSOFR(M)3.25%6.97%04/20329,3139,3089,316
Cohnreznick Advisory LLCFinancial Services & TechnologySOFR(Q)3.50%7.17%03/20329,1149,0929,177
Confluent Health, LLCHealthcareSOFR(M)4.00%7.83%11/20284,6034,5924,120
Confluent Medical Technologies, Inc.HealthcareSOFR(Q)3.00%6.67%02/20296,7406,7236,799
ConnectWise, LLCSoftwareSOFR(Q)3.50%7.43%09/202811,51211,50211,332
Convey Health Solutions, Inc.HealthcareSOFR(Q)1.00% + 3.94%/PIK8.71%07/20299,1239,0126,661
Cornerstone OnDemand, Inc.SoftwareSOFR(M)3.75%7.58%10/20282,5332,5272,335
CVET Midco 2, L.P.Distribution & LogisticsSOFR(Q)5.00%8.67%10/20299,7069,4108,749
Dealer Tire Financial, LLCDistribution & LogisticsSOFR(M)3.00%6.72%07/203111,43511,38811,464
DG Investment Intermediate Holdings 2, Inc.Business ServicesSOFR(M)3.75%7.47%07/203211,00810,95911,050
Disco Parent, Inc.SoftwareSOFR(Q)3.25%7.07%08/20327,2507,2337,304
Discovery Purchaser CorporationSpecialty Chemicals & MaterialsSOFR(Q)3.75%7.61%10/202913,85613,49613,349
EAB Global, Inc.EducationSOFR(M)3.00%6.72%08/203010,0839,8818,990
Eagle Parent Corp.Business ServicesSOFR(Q)4.25%7.92%04/202913,86613,70913,920
Eisner Advisory Group LLCFinancial Services & TechnologySOFR(M)4.00%7.72%02/20318,5468,4948,617
Embecta Corp.HealthcareSOFR(M)3.00%6.72%03/20294,0024,0124,015
Finastra USA, Inc.Financial Services & TechnologySOFR(Q)4.00%7.72%09/203212,37312,25912,135
First Advantage Holdings, LLCBusiness ServicesSOFR(M)2.75%6.47%10/20314,2234,1814,186
Flash Charm, Inc.SoftwareSOFR(Q)3.50%7.35%03/202816,34116,33315,290
FNZ Group Entities LimitedFinancial Services & TechnologySOFR(Q)5.00%8.90%11/203110,1789,9978,099
Forgent Intermediate IV LLCBusiness ProductsSOFR(M)3.25%6.90%12/203212,74912,62112,685
Foundational Education Group, Inc.EducationSOFR(Q)3.75%7.85%08/202814,06313,98413,001
Groundworks, LLCBusiness ServicesSOFR(M)3.00%6.73%03/203110,1009,87110,163
Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal Amount or Par ValueCostFair Value (2)
Heartland Dental, LLCHealthcareSOFR(M)3.75%7.47%08/2032$13,896$13,862$13,970
Help/Systems Holdings, Inc.SoftwareSOFR(Q)6.00%9.97%05/202911,14011,12110,120
HIG Operations Holdings, Inc.Business ServicesSOFR(M)4.50%8.22%06/203111,84911,80611,849
Houghton Mifflin Harcourt CompanyEducationSOFR(M)5.25%9.07%04/20297,9867,8187,069
HP PHRG Borrower, LLCConsumer ServicesSOFR(Q)4.00%7.67%02/203216,64116,53416,572
Inizio Group LimitedHealthcareSOFR(Q)4.25%8.02%08/202812,74712,66912,444
Jones DesLauriers Insurance Management Inc.Business ServicesSOFR(Q)3.00%6.65%02/20332,6872,6802,693
Kaseya Inc.SoftwareSOFR(M)3.00%6.72%03/203212,82012,79712,847
Kestra Advisor Services Holdings A, Inc.Financial Services & TechnologySOFR(M)3.00%6.72%03/20313,7493,7423,760
KnowBe4, Inc.EducationSOFR(Q)3.75%7.59%07/203213,12813,12513,152
LI Group Holdings, Inc.EducationSOFR(M)3.50%7.33%03/20283,0333,0313,055
LSCS Holdings, Inc.HealthcareSOFR(Q)4.50%8.17%03/203214,86314,77414,590
LTR Intermediate Holdings, Inc.Specialty Chemicals & MaterialsSOFR(M)3.75%7.40%12/20327,9177,8787,949
Marcel Bidco LLC (Marcel Bidco GmbH)SoftwareSOFR(M)3.00%6.93%11/20302,8092,7772,826
Mavis Tire Express Services Topco, Corp.RetailSOFR(M)3.00%6.72%05/202812,59312,54912,653
MED ParentCo, LPHealthcareSOFR(M)3.00%6.72%04/20319,8809,8409,921
Michael Baker International, LLCBusiness ServicesSOFR(Q)4.00%7.84%12/20285,5345,5335,553
Neon Maple Purchaser Inc.Financial Services & TechnologySOFR(M)2.50%6.22%11/20313,5103,5233,519
Nexus Buyer LLCFinancial Services & TechnologySOFR(M)4.00%7.72%07/203114,01213,94113,927
Nielsen Consumer, Inc.Business ServicesSOFR(M)2.25%5.97%10/20305,7715,3885,787
Oceankey (U.S.) II Corp.SoftwareSOFR(M)3.50%7.32%12/202814,01414,01913,841
Orbit Private Holdings I LtdFinancial Services & TechnologySOFR(S)3.75%7.55%12/20319,0859,0519,134
Orion Advisor Solutions, Inc.Financial Services & TechnologySOFR(Q)3.25%6.90%09/20301,5001,5011,511
Orion Midco LtdFinancial Services & TechnologySOFR(Q)3.50%7.43%10/20328,1028,0958,150
Osaic Holdings, Inc.Financial Services & TechnologySOFR(S)3.00%6.60%07/203212,35712,32712,423
Osmose Utilities Services, Inc.Specialty Chemicals & MaterialsSOFR(M)3.25%7.08%06/202813,95113,43013,742
Outcomes Group Holdings, Inc.HealthcareSOFR(M)3.00%6.72%05/20314,0884,0744,119
OVG Business Services, LLCBusiness ServicesSOFR(M)3.00%6.72%06/20312,7692,7552,778
Pearls (Netherlands) Bidco B.V.Specialty Chemicals & MaterialsSOFR(Q)3.25%7.09%02/20298,9598,5768,123
Perforce Software, Inc.SoftwareSOFR(M)4.75%8.47%03/20314,0354,0213,426
Physician Partners, LLCHealthcareSOFR(Q)6.00%9.67%12/20292,3602,3031,974
Physician Partners, LLCHealthcareSOFR(Q)1.50% +2.50%/PIK7.82%12/20292,8052,7901,353
Pioneer AcquisitionCo, LLCBusiness ServicesSOFR(Q)3.25%6.94%10/20327,9247,9047,968
Planview Parent, Inc.SoftwareSOFR(Q)3.50%7.17%12/202713,50313,39712,995
Project Alpha Intermediate Holding, Inc.SoftwareSOFR(Q)3.25%6.92%10/203013,50513,30213,500
Pushpay USA Inc.Financial Services & TechnologySOFR(S)3.75%7.62%08/203113,90313,88413,911
Quartz AcquireCo, LLCBusiness ServicesSOFR(Q)2.25%5.92%06/20303,5103,4973,510
RealPage, Inc.SoftwareSOFR(Q)3.00%6.93%04/20283,0473,0433,048
RealPage, Inc.SoftwareSOFR(Q)3.75%7.42%04/20284,9634,9454,985
Rithum Holdings, Inc. (fka CommerceHub, Inc.)SoftwareSOFR(Q)4.75%8.42%07/203215,74415,64415,769
RLG Holdings, LLCPackagingSOFR(M)4.25%8.08%07/20287,1066,8434,372
RxB Holdings, Inc.HealthcareSOFR(M)5.00%8.65%12/20305,1565,0535,098
Secretariat Advisors LLCBusiness ServicesSOFR(Q)4.00%7.67%02/20328,9578,9208,994
Secure Acquisition, Inc.PackagingSOFR(Q)3.75%7.42%12/2028500501505
Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal Amount or Par ValueCostFair Value (2)
SonarSource Financing, LLCSoftwareSOFR(M)4.50%8.15%12/2030$11,485$11,313$11,370
Sovos Compliance, LLC (fka Taxware, LLC)SoftwareSOFR(M)3.25%6.97%08/20298,7678,7758,803
Spring Education Group, Inc.EducationSOFR(Q)3.25%6.92%10/203013,16313,05113,254
Storable, Inc.SoftwareSOFR(M)3.25%6.97%04/20314,6074,6064,635
Summit Acquisition Inc.Business ServicesSOFR(M)3.50%7.22%10/20315,9705,9446,022
Symplr Software, Inc.HealthcareSOFR(Q)4.50%8.44%12/202715,24015,19312,984
Team.blue Finco SARLSoftwareSOFR(Q)3.25%6.92%07/20328,5868,5958,642
Therapy Brands Holdings LLCHealthcareSOFR(M)4.00%7.83%05/20283,9753,9663,679
Thermostat Purchaser III, Inc.Business ServicesSOFR(Q)4.25%7.92%08/202813,50613,50113,483
TransDigm Inc.ManufacturingSOFR(M)2.50%6.22%08/20323,5103,5193,529
TransDigm Inc.ManufacturingSOFR(M)2.50%6.22%02/20312,1062,1112,116
TRC Companies LLCBusiness ServicesSOFR(M)3.00%6.72%12/20289,3779,3529,418
Tricorbraun Holdings, Inc.PackagingSOFR(M)3.25%6.97%03/203111,12211,08310,798
US Fertility Enterprises, LLCHealthcareSOFR(M)3.50%7.22%12/20326,8756,8416,910
Valcour Packaging, LLCPackagingSOFR(M)5.25%8.99%10/20282,2562,2382,282
Valcour Packaging, LLCPackagingSOFR(M)1.50% + 2.25%/PIK7.60%10/20283,1783,1782,480
Viant Medical Holdings, Inc.HealthcareSOFR(M)4.00%7.72%10/203111,45411,43411,358
VSTG Intermediate Holdings, Inc.Business ServicesSOFR(Q)3.75%7.42%07/202911,18911,18011,189
VT Topco, Inc.Business ServicesSOFR(M)3.00%6.87%08/203010,67210,52010,541
Xplor T1, LLCFinancial Services & TechnologySOFR(Q)3.50%7.29%12/203219,79119,70619,840
Zelis Cost Management Buyer, Inc.HealthcareSOFR(M)3.25%6.97%11/203119,46319,46319,342
Zest Acquisition Corp.HealthcareSOFR(Q)5.25%9.11%02/20285,2365,1605,236
Total Funded Investments$964,692$957,258$941,399
Unfunded Investments - First lien
Citrin Cooperman Advisors LLCFinancial Services & Technology———04/2027$2,273$(23)$9
Cohnreznick Advisory LLCFinancial Services & Technology———03/20271,344(3)9
HIG Operations Holdings, Inc.Business Services———09/20261,121——
Secretariat Advisors LLCBusiness Services———02/20271,087—5
US Fertility Enterprises, LLCHealthcare———12/20271,042—5
Total Unfunded Investments$6,867$(26)$28
Total Investments$971,559$957,232$941,427

(1)All interest is payable in cash unless otherwise indicated. All of the variable rate debt investments bear interest at a rate that may be determined by reference to the Secured Overnight Financing Rate (SOFR). For each investment, the current interest rate provided reflects the rate in effect as of December 31, 2025.

(2)Represents the fair value in accordance with Accounting Standards Codification Topic 820, Fair Value Measurement and Disclosures ("ASC 820"). The Company's board of directors does not determine the fair value of the investments held by SLP III.

Below is certain summarized financial information for SLP III as of September 30, 2026 and December 31, 2025 and for the three and nine months ended September 30, 2026 and September 30, 2025:

Selected Balance Sheet Information:September 30, 2026December 31, 2025
Investments at fair value (cost of $920,103 and $957,232, respectively)$872,188$941,427
Cash and other assets30,66128,469
Receivable from unsettled securities sold30,775—
Total assets$933,624$969,896
Credit facility$758,200$672,700
Deferred financing costs (net of accumulated amortization of $8,861 and $7,948, respectively)(3,394)(4,308)
Payable for unsettled securities purchased15,116105,171
Distribution payable4,6257,000
Other liabilities10,3008,462
Total liabilities784,847789,025
Members' capital$148,777$180,871
Total liabilities and members' capital$933,624$969,896
Selected Statement of Operations Information:Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Interest income$18,796$16,172$56,176$46,239
Other income9364526253
Total investment income18,88916,23656,70246,492
Interest and other financing expenses11,8958,22735,25024,444
Other expenses3493291,070932
Total expenses12,2448,55636,32025,376
Net investment income6,6457,68020,38221,116
Net realized losses on investments(913)(1,294)(2,541)(829)
Net change in unrealized appreciation (depreciation) of investments9,441(1,122)(32,110)(9,439)
Net increase (decrease) in members' capital$15,173$5,264$(14,269)$10,848

For the three and nine months ended September 30, 2026, the Company earned approximately $3,700 and $14,260, respectively, of dividend income related to SLP III, which is included in dividend income. For the three and nine months ended September 30, 2025, the Company earned approximately $5,600 and $17,000, respectively, of dividend income related to SLP III, which is included in dividend income. As of September 30, 2026 and December 31, 2025, approximately $3,700 and $5,600, respectively, of dividend income related to SLP III was included in interest and dividend receivable.

The Company has determined that SLP III is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly-owned investment company subsidiary. Furthermore, ASC 810 concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate SLP III.

NMFC Senior Loan Program IV LLC

NMFC Senior Loan Program IV LLC ("SLP IV") was formed as a Delaware limited liability company on April 6, 2021, and commenced operations on May 5, 2021. SLP IV is structured as a private joint venture investment fund between the Company and SkyKnight Income Alpha, LLC ("SkyKnight Alpha") and operates under the First Amended and Restated Limited Liability Company Agreement of NMFC Senior Loan Program IV LLC, dated May 5, 2021 (the "SLP IV Agreement"). Upon the effectiveness of the SLP IV Agreement, the members contributed their respective membership interests in NMFC Senior Loan Program I LLC ("SLP I") and NMFC Senior Loan Program II LLC ("SLP II") to SLP IV. Immediately following the contribution of their membership interests, SLP I and SLP II became wholly-owned subsidiaries of SLP IV. The purpose of the joint venture is to invest primarily in senior secured loans issued by portfolio companies within the Company's core industry verticals. These investments are typically broadly syndicated first lien loans. All investment decisions must be unanimously approved by the board of managers of SLP IV, which has equal representation from the Company and SkyKnight Alpha. SLP IV initially had afive-year investment period and will continue in existence until July 11, 2030. On July 11, 2025, the investment period was extended until July 11, 2028. The investment period may be extended for up toone additional year subject to certain conditions.

SLP IV is capitalized with equity contributions which were transferred and contributed from its members. As of September 30, 2026, the Company and SkyKnight Alpha have transferred and contributed $112,400 and $30,600, respectively, of their membership interests in SLP I and SLP II to SLP IV. The Company’s investment in SLP IV is disclosed on the Company’s Consolidated Schedule of Investments as of September 30, 2026 and December 31, 2025.

On May 5, 2021, SLP IV entered into a revolving credit facility with Wells Fargo Bank, National Association. As of the amendment on July 11, 2025, the maturity date of SLP IV's revolving credit facility was extended to July 11, 2030.

On July 11, 2025, SLP IV entered into an amendment to add a subordinate lender (“Class B lenders”) to the existing lender (“Class A lenders”). As of the amendment on July 11, 2025, SLP IV's revolving credit facility has a maximum borrowing capacity of $600,000, of which $530,000 of the facility amount is attributed to Class A lenders and $70,000 of the facility amount is attributed to Class B lenders. Prior to the amendment on July 11, 2025, SLP IV's revolving credit facility had a maximum borrowing capacity of $370,000, with the full amount attributable to one class of lenders. As of the amendment on July 11, 2025, Class A advances bear interest at a rate of SOFR plus 1.50% and Class B advances bear interest at a rate of SOFR plus 4.75%. From December 20, 2024 to July 11, 2025, the facility bore interest at a rate of SOFR plus 1.50%.

As of September 30, 2026 and December 31, 2025, SLP IV had total investments with an aggregate fair value of approximately $592,086 and $641,452, respectively, and debt outstanding under its credit facility of $522,137 and $471,737, respectively. Additionally, as of September 30, 2026 and December 31, 2025, SLP IV had unfunded commitments in the form of delayed draws of $1,623 and $4,796, respectively.

During the first quarter of 2026, SLP IV placed its first lien position in Convey on non-accrual status. As of September 30, 2026, SLP IV's first lien position in Convey had total unearned income of $77 and $241, respectively, for the three and nine months then ended.

Below is a summary of SLP IV's consolidated portfolio, along with a listing of the individual investments in SLP IV's consolidated portfolio as of September 30, 2026 and December 31, 2025:

September 30, 2026December 31, 2025
First lien investments (1)$633,916$664,399
Weighted average interest rate on first lien investments (2)7.77%8.67%
Number of portfolio companies in SLP IV105105
Largest portfolio company investment (1)$18,327$18,217
Total of five largest portfolio company investments (1)$64,843$64,111

The following table is a listing of the individual investments in SLP IV's consolidated portfolio as of September 30, 2026:

Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal AmountCostFair Value (2)
Funded Investments - First lien
Accelya Lux Finco S.a r.l.Business ServicesSOFR(Q)5.25%9.32%10/2032$10,420$10,232$9,430
ADG, LLCHealthcareSOFR(Q)1.00% + 3.00%/PIK7.88%09/202818,32718,32611,846
ADMI Corp. (aka Aspen Dental)HealthcareSOFR(M)3.75%7.77%12/20271,7811,7791,688
Allium Buyer LLCBusiness ServicesSOFR(Q)4.25%8.30%09/20316,0285,9386,051
AmSpec Parent, LLCEnergySOFR(Q)3.00%7.07%12/20315,4785,4735,498
Asurion, LLCBusiness ServicesSOFR(Q)3.75%7.57%02/20333,1343,1182,911
athenahealth Group Inc.HealthcareSOFR(M)3.25%7.15%02/20325,2345,2175,234
BCPE Empire Holdings, Inc.Distribution & LogisticsSOFR(M)3.25%7.15%12/20307,8387,8097,593
BCPE Empire Holdings, Inc.Distribution & LogisticsSOFR(M)3.50%7.40%12/20323,6333,5833,505
Bella Holding Company, LLCHealthcareSOFR(M)3.25%7.15%06/20331,7291,7141,733
Berlin Packaging L.L.C.PackagingSOFR(Q)3.25%7.22%06/20314,8904,8924,860
BIFM CA Buyer Inc.Business ServicesSOFR(M)3.25%7.15%05/20286,5616,5476,567
Cardinal Parent, Inc.Financial Services & TechnologySOFR(Q)4.50%8.72%11/20276,9906,9306,287
Chrysaor Bidco S.a r.l.Financial Services & TechnologySOFR(Q)3.00%6.76%10/20311,5491,5491,556
Citrin Cooperman Advisors LLCFinancial Services & TechnologySOFR(Q)3.00%7.07%04/20322,6772,6652,648
Cleanova US Holdings LLCBusiness ProductsSOFR(Q)4.75%8.61%06/203211,09610,98811,103
Cloudera, Inc.SoftwareSOFR(M)3.75%7.75%10/20289,5509,4758,924
Clydesdale Acquisition Holdings, Inc.PackagingSOFR(M)3.25%7.15%04/20325,5045,5055,410
Cohnreznick Advisory LLCFinancial Services & TechnologySOFR(Q)3.25%7.32%03/20324,4104,3974,380
Confluence Technologies, Inc.SoftwareSOFR(Q)3.75%7.97%07/20289,5259,5107,772
Confluence Technologies, Inc.SoftwareSOFR(Q)5.00%8.76%07/2028943943941
Confluent Health, LLCHealthcareSOFR(M)4.00%8.02%11/20283,0573,0512,856
ConnectWise, LLCSoftwareSOFR(Q)3.50%7.84%09/20286,5556,5616,450
Convey Health Solutions, Inc. (3)HealthcareSOFR(Q)1.31% + 2.63%/PIK8.11%07/20293,4843,349376
CoreLogic, Inc. (fka First American Corporation, The)Business ServicesSOFR(M)4.25%8.15%07/20316,5006,3746,167
Cornerstone OnDemand, Inc.SoftwareSOFR(M)3.75%7.77%10/20281,7951,7921,139
Cub Financing Intermediate, LLCFinancial Services & TechnologySOFR(Q)4.25%8.33%08/2033589583593
CVET Midco 2, L.P.Distribution & LogisticsSOFR(Q)5.00%9.07%10/20296,4726,3746,300
Dayforce Bidco, LLCSoftwareSOFR(Q)3.00%6.82%02/20332,9962,9192,889
Dealer Tire Financial, LLCDistribution & LogisticsSOFR(M)3.00%6.90%07/203110,29710,25910,215
DG Investment Intermediate Holdings 2, Inc.Business ServicesSOFR(M)3.00%6.90%07/20328,2268,2088,247
Discovery Purchaser CorporationSpecialty Chemicals & MaterialsSOFR(Q)3.75%7.48%10/20296,8166,6536,800
EAB Global, Inc.EducationSOFR(M)3.00%6.90%08/20306,8246,7606,081
Eagle Parent Corp.Business ServicesSOFR(Q)4.25%8.32%04/20298,7758,7038,834
Eisner Advisory Group LLCFinancial Services & TechnologySOFR(M)4.00%7.90%02/20316,8266,7616,823
Embecta Corp.HealthcareSOFR(Q)3.00%7.07%03/20291,5791,5821,340
Finastra USA, Inc.Financial Services & TechnologySOFR(S)4.00%7.75%09/20328,2148,1477,943
Flash Charm, Inc.SoftwareSOFR(Q)3.50%7.31%03/20283,8983,8903,443
FNZ Group Entities LimitedFinancial Services & TechnologySOFR(Q)5.00%8.76%11/20317,1617,0484,630
Foundational Education Group, Inc.EducationSOFR(Q)4.25%8.33%08/202810,84410,78710,129
Groundworks, LLCBusiness ServicesSOFR(M)3.50%7.40%03/20316,4046,3756,412
Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal AmountCostFair Value (2)
Heartland Dental, LLCHealthcareSOFR(M)3.00%6.82%08/2032$2,652$2,648$2,650
Help/Systems Holdings, Inc.SoftwareSOFR(Q)6.00%9.86%05/20296,0025,9954,549
HIG Finance 2 LimitedFinancial Services & TechnologySOFR(M)2.75%6.65%02/20312,9772,8892,873
HIG Operations Holdings, Inc.Business ServicesSOFR(M)4.50%8.40%06/20317,0697,0697,069
HIG Operations Holdings, Inc.Business ServicesSOFR(M)4.50%8.40%06/20311,2301,2241,229
Houghton Mifflin Harcourt CompanyEducationSOFR(M)5.25%9.25%04/20298,1097,9535,524
HP PHRG Borrower, LLCConsumer ServicesSOFR(Q)4.00%8.07%02/203210,51710,45410,474
Inizio Group LimitedHealthcareSOFR(Q)4.25%8.42%08/20289,7029,6249,496
Jones DesLauriers Insurance Management Inc.Business ServicesSOFR(Q)3.00%6.82%02/20333,0993,0393,063
Kaseya Inc.SoftwareSOFR(Q)3.25%7.07%03/20328,0908,0766,773
KnowBe4, Inc.EducationSOFR(Q)3.75%7.57%07/20324,7514,7513,369
LSCS Holdings, Inc.HealthcareSOFR(Q)4.50%8.57%03/203210,11910,07210,063
LTR Intermediate Holdings, Inc.Specialty Chemicals & MaterialsSOFR(M)3.75%7.64%12/20325,0164,9935,035
Marcel Bidco LLC (Marcel Bidco GmbH)SoftwareSOFR(M)3.00%6.87%11/20302,9992,9752,928
Mavis Tire Express Services Topco, Corp.RetailSOFR(Q)3.25%6.92%05/20338,8758,8318,802
MED ParentCo, LPHealthcareSOFR(M)3.00%6.90%04/20316,0396,0176,036
Michael Baker International, LLCBusiness ServicesSOFR(Q)4.00%7.82%12/20283,8003,8003,806
Michael Baker International, LLCBusiness ServicesSOFR(M)4.50%8.40%12/20281,2591,2301,261
Neon Maple Purchaser Inc.Financial Services & TechnologySOFR(M)2.50%6.40%11/20312,2102,2132,153
Nexus Buyer LLCFinancial Services & TechnologySOFR(M)4.00%7.90%07/20318,8428,8028,761
Nielsen Consumer, Inc.Business ServicesSOFR(M)2.25%6.15%10/20303,6543,5013,643
Oceankey (U.S.) II Corp.SoftwareSOFR(M)3.50%7.50%12/20289,1679,1709,070
OCM System One Buyer CTB, LLC (Sentinel Purchaser II Holdco, LLC)Business ServicesSOFR(M)3.75%7.65%08/20334,8234,7994,817
Orbit Private Holdings I LtdFinancial Services & TechnologySOFR(S)3.75%7.60%12/20315,9415,9215,951
Osaic Holdings, Inc.Financial Services & TechnologySOFR(Q)2.50%6.57%07/20323,5323,5323,504
Osmose Utilities Services, Inc.Specialty Chemicals & MaterialsSOFR(M)3.25%7.27%06/20288,8058,5708,795
OSTTRA Group LtdFinancial Services & TechnologySOFR(Q)3.00%6.75%10/20325,6225,6175,629
Outcomes Group Holdings, Inc.HealthcareSOFR(Q)3.00%6.76%05/20312,8082,7992,824
OVG Business Services, LLCBusiness ServicesSOFR(M)3.00%6.90%06/20311,7501,7421,759
Paradigm Parent, LLCDistribution & LogisticsSOFR(Q)4.50%8.57%04/2032398354372
Pearls (Netherlands) Bidco B.V.Specialty Chemicals & MaterialsSOFR(Q)3.25%7.07%02/2029762737723
Perforce Software, Inc.SoftwareSOFR(M)4.75%8.65%03/20313,1733,1631,629
Physician Partners, LLCHealthcareSOFR(Q)6.00%10.07%12/20292,7632,6732,804
Physician Partners, LLCHealthcareSOFR(Q)4.00%8.22%12/20292,1472,1372,075
Pioneer AcquisitionCo, LLCBusiness ServicesSOFR(Q)2.50%6.57%10/20324,0134,0043,993
Planview Parent, Inc.SoftwareSOFR(Q)3.50%7.57%12/20277,8797,8406,599
Pretium PKG Holdings, Inc.PackagingSOFR(Q)5.25%8.98%03/20313,5663,5503,538
Project Alpha Intermediate Holding, Inc.SoftwareSOFR(Q)3.25%7.32%10/20309,6349,5086,809
Pushpay USA Inc.Financial Services & TechnologySOFR(Q)3.75%7.57%08/20318,7868,7907,966
Quartz AcquireCo, LLCBusiness ServicesSOFR(Q)2.25%6.32%06/20301,1021,098960
RealPage, Inc.SoftwareSOFR(Q)3.00%7.34%04/20283,5083,5023,466
RealPage, Inc.SoftwareSOFR(Q)3.75%7.82%04/20284,0634,0064,024
Rithum Holdings, Inc. (fka CommerceHub, Inc.)SoftwareSOFR(Q)4.75%8.82%07/20329,9859,9219,421
RxB Holdings, Inc.HealthcareSOFR(M)5.00%8.90%12/20303,2423,1853,246
Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal AmountCostFair Value (2)
Secretariat Advisors LLCBusiness ServicesSOFR(Q)4.00%8.07%02/2032$6,249$6,227$6,060
Secure Acquisition, Inc.PackagingSOFR(M)3.75%7.65%12/20282,5802,5782,588
SonarSource Financing, LLCSoftwareSOFR(Q)4.50%8.23%12/20306,8346,7446,663
Sovos Compliance, LLC (fka Taxware, LLC)SoftwareSOFR(M)3.25%7.15%08/20296,6606,6176,486
Spring Education Group, Inc.EducationSOFR(Q)3.25%7.32%10/203010,07610,00110,086
STATS Intermediate Holdings, LLCBusiness ServicesSOFR(Q)7.00%10.74%04/20306,9656,7406,904
Storable, Inc.SoftwareSOFR(M)3.25%7.15%04/20315,5475,5224,806
Summit Acquisition Inc.Business ServicesSOFR(M)3.50%7.40%10/2031744743747
Sword Purchaser, LLCPackagingSOFR(M)4.00%7.90%04/20332,8402,7052,838
Symplr Software, Inc.HealthcareSOFR(Q)4.50%8.42%12/20273,6213,6183,035
Team.blue Finco SARLSoftwareSOFR(Q)3.25%7.32%07/20325,9855,9785,873
Tegra118 Wealth Solutions, Inc.Financial Services & TechnologySOFR(Q)4.00%7.82%01/20337,3047,2497,347
Tempo Acquisition, LLCBusiness ServicesSOFR(M)1.75%5.65%08/20282,2861,9701,820
Therapy Brands Holdings LLCHealthcareSOFR(Q)4.00%8.03%05/20285,8015,7925,801
Thermostat Purchaser III, Inc.Business ServicesSOFR(Q)4.25%8.32%08/20288,5518,5478,430
Tricorbraun Holdings, Inc.PackagingSOFR(M)3.25%7.15%03/20317,0277,0056,738
TruGreen Limited PartnershipConsumer ServicesSOFR(M)4.00%8.00%11/20273,3853,2443,306
UKG Inc.SoftwareSOFR(Q)2.25%6.07%02/20313,4283,3723,331
US Fertility Enterprises, LLCHealthcareSOFR(Q)3.00%7.07%12/20324,7474,7254,763
Valcour Packaging, LLCPackagingSOFR(M)5.25%9.15%10/20286,9436,9757,006
Valcour Packaging, LLCPackagingSOFR(M)3.75%7.76%10/20282,3372,3361,861
Viant Medical Holdings, Inc.HealthcareSOFR(M)4.00%7.90%10/20317,6867,6687,562
VSTG Intermediate Holdings, Inc.Business ServicesSOFR(Q)3.75%7.82%07/20297,0277,0216,917
Xplor T1, LLCFinancial Services & TechnologySOFR(Q)3.25%7.05%12/203210,75310,71010,404
Zelis Cost Management Buyer, Inc.HealthcareSOFR(M)3.25%7.15%11/203112,30012,30112,257
Zest Acquisition Corp.HealthcareSOFR(M)6.00%9.90%02/20313,8793,8213,821
Zone Climate Services, Inc.Business ServicesSOFR(Q)5.50%9.38%03/20289,5509,4959,454
Zone Climate Services, Inc.Business ServicesSOFR(Q)5.50%9.38%03/20282,0992,0872,078
Total Funded Investments$632,293$627,331$592,117
Unfunded Investments - First lien
Citrin Cooperman Advisors LLCFinancial Services & Technology———04/2027$615$(6)$(9)
Secretariat Advisors LLCBusiness Services———02/2027764—(23)
US Fertility Enterprises, LLCHealthcare———12/2027244(1)1
Total Unfunded Investments$1,623$(7)$(31)
Total Investments$633,916$627,324$592,086

(1)All interest is payable in cash unless otherwise indicated. All of the variable rate debt investments bear interest at a rate that may be determined by reference to the Secured Overnight Financing Rate (SOFR). For each investment, the current interest rate provided reflects the rate in effect as of September 30, 2026.

(2)Represents the fair value in accordance with ASC 820. The Company's board of managers does not determine the fair value of the investments held by SLP IV.

(3)Investment is on non-accrual status as of September 30, 2026.

The following table is a listing of the individual investments in SLP IV's consolidated portfolio as of December 31, 2025:

Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal Amount or Par ValueCostFair Value (2)
Funded Investments - First lien
Accelya Lux Finco S.a r.l.Business ServicesSOFR(Q)5.25%8.92%10/2032$10,498$10,292$10,466
ADG, LLCHealthcareSOFR(Q)1.00% +3.00%/PIK7.82%09/202618,21718,21514,574
ADMI Corp. (aka Aspen Dental)HealthcareSOFR(M)3.75%7.58%12/20271,7951,7921,708
AmSpec Parent, LLCEnergySOFR(Q)3.50%7.17%12/20315,5195,5145,547
Asurion, LLCBusiness ServicesSOFR(M)4.25%8.07%08/20289,5939,5429,622
Asurion, LLCBusiness ServicesSOFR(M)4.25%7.97%09/20301,8091,7591,811
Asurion, LLCBusiness ServicesSOFR(M)4.25%7.97%09/2030992979994
athenahealth Group Inc.HealthcareSOFR(M)2.75%6.47%02/20294,7224,7174,737
Bach Finance LimitedEducationSOFR(Q)2.75%6.57%01/20321,5951,5921,602
BCPE Empire Holdings, Inc.Distribution & LogisticsSOFR(M)3.25%6.97%12/20308,5098,4738,434
Bella Holding Company, LLCHealthcareSOFR(M)3.00%6.72%05/20281,7371,7361,746
Berlin Packaging L.L.C.PackagingSOFR(M)3.25%7.11%06/20314,9274,9304,944
BIFM CA Buyer Inc.Business ServicesSOFR(M)3.25%6.97%05/20286,6116,5856,664
Boxer Parent Company Inc.SoftwareSOFR(Q)3.00%6.82%07/20315,2165,2055,208
BradyPLUS Holdings, LLCDistribution & LogisticsSOFR(Q)3.50%7.15%12/20323,6503,5963,618
BW Holding, Inc.PackagingSOFR(Q)6.50%10.34%12/2030445441454
Capstone Borrower, Inc.SoftwareSOFR(Q)2.75%6.40%06/20301,9891,9791,991
Cardinal Parent, Inc.Financial Services & TechnologySOFR(Q)4.50%8.32%11/20277,0466,9476,898
Chrysaor Bidco S.a r.l.Financial Services & TechnologySOFR(Q)3.25%7.14%10/20311,5611,5611,574
Citrin Cooperman Advisors LLCFinancial Services & TechnologySOFR(Q)3.00%6.67%04/20324,1794,1734,196
Cleanova US Holdings LLCBusiness ProductsSOFR(Q)4.75%8.48%06/203211,97311,84611,973
Cloudera, Inc.SoftwareSOFR(M)3.75%7.57%10/20289,6259,5249,247
Clydesdale Acquisition Holdings, Inc.PackagingSOFR(M)3.25%6.97%04/20325,5215,5235,525
Cohnreznick Advisory LLCFinancial Services & TechnologySOFR(Q)3.50%7.17%03/20325,4755,4635,513
Confluence Technologies, Inc.SoftwareSOFR(Q)3.75%7.57%07/20289,6009,5798,058
Confluence Technologies, Inc.SoftwareSOFR(Q)5.00%8.85%07/2028943942943
Confluent Health, LLCHealthcareSOFR(M)4.00%7.83%11/20283,0823,0742,758
Confluent Medical Technologies, Inc.HealthcareSOFR(Q)3.00%6.67%02/20296,7406,7236,799
ConnectWise, LLCSoftwareSOFR(Q)3.50%7.43%09/20286,6066,6146,503
Convey Health Solutions, Inc.HealthcareSOFR(Q)1.00% +3.94%/PIK8.71%07/20293,5093,4662,562
Cornerstone OnDemand, Inc.SoftwareSOFR(M)3.75%7.58%10/20281,8091,8051,668
CVET Midco 2, L.P.Distribution & LogisticsSOFR(Q)5.00%8.67%10/20296,5226,4025,879
Dealer Tire Financial, LLCDistribution & LogisticsSOFR(M)3.00%6.72%07/203110,37610,33310,402
DG Investment Intermediate Holdings 2, Inc.Business ServicesSOFR(M)3.75%7.47%07/20327,2837,2647,310
Disco Parent, Inc.SoftwareSOFR(Q)3.25%7.07%08/20324,6254,6144,660
Discovery Purchaser CorporationSpecialty Chemicals & MaterialsSOFR(Q)3.75%7.61%10/20299,2278,9588,889
EAB Global, Inc.EducationSOFR(M)3.00%6.72%08/20306,8766,8016,131
Eagle Parent Corp.Business ServicesSOFR(Q)4.25%7.92%04/20298,8448,7538,878
Eisner Advisory Group LLCFinancial Services & TechnologySOFR(M)4.00%7.72%02/20314,9764,9375,017
Embecta Corp.HealthcareSOFR(M)3.00%6.72%03/20291,6841,6881,689
Finastra USA, Inc.Financial Services & TechnologySOFR(Q)4.00%7.72%09/20328,2558,1818,097
First Advantage Holdings, LLCBusiness ServicesSOFR(M)2.75%6.47%10/20311,7771,7591,762
Flash Charm, Inc.SoftwareSOFR(Q)3.50%7.35%03/20289,9559,9249,315
Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal Amount or Par ValueCostFair Value (2)
FNZ Group Entities LimitedFinancial Services & TechnologySOFR(Q)5.00%8.90%11/2031$7,216$7,088$5,742
Forgent Intermediate IV LLCBusiness ProductsSOFR(M)3.25%6.90%12/20328,1188,0378,077
Foundational Education Group, Inc.EducationSOFR(Q)3.75%7.85%08/202810,93010,85210,105
Groundworks, LLCBusiness ServicesSOFR(M)3.00%6.73%03/20316,4526,2976,492
Heartland Dental, LLCHealthcareSOFR(M)3.75%7.47%08/20329,9109,8869,963
Help/Systems Holdings, Inc.SoftwareSOFR(Q)6.00%9.97%05/20296,0476,0395,494
HIG Operations Holdings, Inc.Business ServicesSOFR(M)4.50%8.22%06/20317,1237,1237,123
Houghton Mifflin Harcourt CompanyEducationSOFR(M)5.25%9.07%04/20298,1727,9757,233
Inizio Group LimitedHealthcareSOFR(Q)4.25%8.02%08/20289,7029,5959,472
Jones DesLauriers Insurance Management Inc.Business ServicesSOFR(Q)3.00%6.65%02/20331,7111,7071,715
Kaseya Inc.SoftwareSOFR(M)3.00%6.72%03/20328,1528,1358,169
Kestra Advisor Services Holdings A, Inc.Financial Services & TechnologySOFR(M)3.00%6.72%03/20312,2802,2772,287
KnowBe4, Inc.EducationSOFR(Q)3.75%7.59%07/20328,7618,7628,778
LSCS Holdings, Inc.HealthcareSOFR(Q)4.50%8.17%03/203210,19710,14410,010
LTR Intermediate Holdings, Inc.Specialty Chemicals & MaterialsSOFR(M)3.75%7.40%12/20325,0415,0165,061
Marcel Bidco LLC (Marcel Bidco GmbH)SoftwareSOFR(M)3.00%6.93%11/20302,0191,9962,032
Mavis Tire Express Services Topco, Corp.RetailSOFR(M)3.00%6.72%05/20288,4938,4738,533
MED ParentCo, LPHealthcareSOFR(M)3.00%6.72%04/20317,2917,2597,321
Michael Baker International, LLCBusiness ServicesSOFR(Q)4.00%7.84%12/20283,8293,8293,843
Neon Maple Purchaser Inc.Financial Services & TechnologySOFR(M)2.50%6.22%11/20311,4771,4831,481
Nexus Buyer LLCFinancial Services & TechnologySOFR(M)4.00%7.72%07/20318,9098,8648,855
Nielsen Consumer, Inc.Business ServicesSOFR(M)2.25%5.97%10/20303,6823,5043,692
Oceankey (U.S.) II Corp.SoftwareSOFR(M)3.50%7.32%12/20289,2399,2439,126
Orbit Private Holdings I LtdFinancial Services & TechnologySOFR(S)3.75%7.55%12/20315,7855,7635,816
Orion Advisor Solutions, Inc.Financial Services & TechnologySOFR(Q)3.25%6.90%09/2030955956962
Orion Midco LtdFinancial Services & TechnologySOFR(Q)3.50%7.43%10/20325,2375,2315,267
Osaic Holdings, Inc.Financial Services & TechnologySOFR(S)3.00%6.60%07/20328,8838,8618,930
Osmose Utilities Services, Inc.Specialty Chemicals & MaterialsSOFR(M)3.25%7.08%06/20288,8758,5438,742
Outcomes Group Holdings, Inc.HealthcareSOFR(M)3.00%6.72%05/20312,8292,8192,850
OVG Business Services, LLCBusiness ServicesSOFR(M)3.00%6.72%06/20311,7631,7551,769
Pearls (Netherlands) Bidco B.V.Specialty Chemicals & MaterialsSOFR(Q)3.25%7.09%02/20295,6795,4365,150
Perforce Software, Inc.SoftwareSOFR(M)4.75%8.47%03/20313,1983,1862,715
Physician Partners, LLCHealthcareSOFR(Q)6.00%9.67%12/20291,7841,7401,492
Physician Partners, LLCHealthcareSOFR(Q)1.50% +2.50%/PIK7.82%12/20292,1202,1091,022
Pioneer AcquisitionCo, LLCBusiness ServicesSOFR(Q)3.25%6.94%10/20325,0465,0335,074
Planview Parent, Inc.SoftwareSOFR(Q)3.50%7.17%12/20277,9407,8767,641
Project Alpha Intermediate Holding, Inc.SoftwareSOFR(Q)3.25%6.92%10/20309,7089,5619,704
Pushpay USA Inc.Financial Services & TechnologySOFR(S)3.75%7.62%08/20318,8538,8588,858
Quartz AcquireCo, LLCBusiness ServicesSOFR(Q)2.25%5.92%06/20301,4771,4721,477
RealPage, Inc.SoftwareSOFR(Q)3.00%6.93%04/20281,9401,9381,941
RealPage, Inc.SoftwareSOFR(Q)3.75%7.42%04/20281,9851,9781,994
Rithum Holdings, Inc. (fka CommerceHub, Inc.)SoftwareSOFR(Q)4.75%8.42%07/203210,0619,99010,076
HP PHRG Borrower, LLCConsumer ServicesSOFR(Q)4.00%7.67%02/203210,59710,52710,553
Portfolio Company and Type of InvestmentIndustryReferenceSpreadInterest Rate (1)Maturity DatePrincipal Amount or Par ValueCostFair Value (2)
RxB Holdings, Inc.HealthcareSOFR(M)5.00%8.65%12/2030$3,283$3,218$3,246
Secretariat Advisors LLCBusiness ServicesSOFR(Q)4.00%7.67%02/20326,1106,0836,134
Secure Acquisition, Inc.PackagingSOFR(Q)3.75%7.42%12/2028330331333
SonarSource Financing, LLCSoftwareSOFR(M)4.50%8.15%12/20307,1006,9947,029
Sovos Compliance, LLC (fka Taxware, LLC)SoftwareSOFR(M)3.25%6.97%08/20295,5615,5665,584
Spring Education Group, Inc.EducationSOFR(Q)3.25%6.92%10/203010,15410,06610,225
STATS Intermediate Holdings, LLCBusiness ServicesSOFR(Q)5.25%9.40%07/20264,9404,9024,868
STATS Intermediate Holdings, LLCBusiness ServicesSOFR(Q)7.25%11.40%07/20262,2252,2102,225
Storable, Inc.SoftwareSOFR(M)3.25%6.97%04/20313,8203,8183,843
Symplr Software, Inc.HealthcareSOFR(Q)4.50%8.44%12/20273,6503,6463,109
Team.blue Finco SARLSoftwareSOFR(Q)3.25%6.92%07/20327,2207,2057,267
Therapy Brands Holdings LLCHealthcareSOFR(M)4.00%7.83%05/20285,8475,8345,412
Thermostat Purchaser III, Inc.Business ServicesSOFR(Q)4.25%7.92%08/20288,6178,6128,602
TransDigm Inc.ManufacturingSOFR(M)2.50%6.22%08/20321,4771,4811,485
TransDigm Inc.ManufacturingSOFR(M)2.50%6.22%02/2031886889891
TRC Companies LLCBusiness ServicesSOFR(M)3.00%6.72%12/20285,3325,3185,355
Tricorbraun Holdings, Inc.PackagingSOFR(M)3.25%6.97%03/20317,0827,0576,876
US Fertility Enterprises, LLCHealthcareSOFR(M)3.50%7.22%12/20324,3784,3564,400
Valcour Packaging, LLCPackagingSOFR(M)5.25%8.99%10/20281,6411,6291,660
Valcour Packaging, LLCPackagingSOFR(M)1.50% +2.25%/PIK7.60%10/20282,3112,3111,804
Viant Medical Holdings, Inc.HealthcareSOFR(M)4.00%7.72%10/20317,7457,7247,680
VSTG Intermediate Holdings, Inc.Business ServicesSOFR(Q)3.75%7.42%07/20297,0827,0747,082
VT Topco, Inc.Business ServicesSOFR(M)3.00%6.87%08/20306,8656,7696,781
Xplor T1, LLCFinancial Services & TechnologySOFR(Q)3.50%7.29%12/203212,56912,51612,600
Zelis Cost Management Buyer, Inc.HealthcareSOFR(M)3.25%6.97%11/203112,39412,39512,316
Zest Acquisition Corp.HealthcareSOFR(Q)5.25%9.11%02/20283,8843,8223,884
Zone Climate Services, Inc.Business ServicesSOFR(Q)5.50%9.52%03/20289,6259,5439,625
Zone Climate Services, Inc.Business ServicesSOFR(Q)5.50%9.52%03/20282,1162,0982,116
Total Funded Investments$659,603$654,884$641,435
Unfunded Investments - First lien
Citrin Cooperman Advisors LLCFinancial Services & Technology———04/2027$1,364$(14)$6
Cohnreznick Advisory LLCFinancial Services & Technology———03/2027791(3)5
HIG Operations Holdings, Inc.Business Services———09/20261,236——
Secretariat Advisors LLCBusiness Services———02/2027742—3
US Fertility Enterprises, LLCHealthcare———12/2027663—3
Total Unfunded Investments$4,796$(17)$17
Total Investments$664,399$654,867$641,452

(1)All interest is payable in cash unless otherwise indicated. All of the variable rate debt investments bear interest at a rate that may be determined by reference to the Secured Overnight Financing Rate (SOFR). For each investment, the current interest rate provided reflects the rate in effect as of December 31, 2025.

(2)Represents the fair value in accordance with ASC 820. The Company's board of directors does not determine the fair value of the investments held by SLP IV.

Below is certain summarized consolidated financial information for SLP IV as of September 30, 2026 and December 31, 2025 and for the three and nine months ended September 30, 2026 and September 30, 2025:

Selected Consolidated Balance Sheet Information:September 30, 2026December 31, 2025
Investments at fair value (cost of $627,324 and $654,867, respectively)$592,086$641,452
Cash and other assets28,47531,324
Receivable from unsettled securities sold24,656—
Total assets$645,217$672,776
Credit facility$522,137$471,737
Deferred financing costs (net of accumulated amortization of $5,290 and $4,022, respectively)(3,176)(4,444)
Payable for unsettled securities purchased9,75966,866
Distribution payable3,2184,826
Other liabilities7,9766,978
Total liabilities539,914545,963
Members' capital$105,303$126,813
Total liabilities and members' capital$645,217$672,776
Selected Consolidated Statement of Operations Information:Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Interest income$13,081$11,308$38,769$31,291
Other income5965360156
Total investment income13,14011,37339,12931,447
Interest and other financing expenses7,9865,98623,99716,171
Other expenses262258872673
Total expenses8,2486,24424,86916,844
Net investment income4,8925,12914,26014,603
Net realized losses on investments(588)(541)(1,613)(681)
Net change in unrealized appreciation (depreciation) of investments3,290(1,569)(21,823)(6,675)
Net increase (decrease) in members' capital$7,594$3,019$(9,176)$7,247

For the three and nine months ended September 30, 2026, the Company earned approximately $2,529 and $9,695, respectively, of dividend income related to SLP IV, which is included in dividend income. For the three and nine months ended September 30, 2025, the Company earned approximately $3,794 and $11,521, respectively, of dividend income related to SLP IV, which is included in dividend income. As of September 30, 2026 and December 31, 2025, approximately $2,529 and $3,794, respectively, of dividend income related to SLP IV was included in interest and dividend receivable.

The Company has determined that SLP IV is an investment company under ASC 946; in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly-owned investment company subsidiary. Furthermore, ASC 810 concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate SLP IV.

Unconsolidated Significant Subsidiaries

In accordance with Regulation S-X Rule 1-02(w)(2), the Company evaluates its unconsolidated controlled portfolio companies to determine if any qualify as “significant subsidiaries.” This determination is made based upon an analysis performed under Rule 10-01(b)(1). As of September 30, 2026, the Company did not have any portfolio companies that were deemed to be a "significant subsidiary."

Investment Risk Factors

First and second lien debt that the Company invests in is almost entirely rated below investment grade or may be unrated. Debt investments rated below investment grade are often referred to as "leveraged loans", "high yield" or "junk" debt investments, and may be considered "high risk" compared to debt investments that are rated investment grade. These debt investments are considered speculative because of the credit risk of the issuers. Such issuers are considered more likely than investment grade issuers to default on their payments of interest and principal, and such risk of default could reduce the net asset value and income distributions of the Company. In addition, some of the Company's debt investments will not fully amortize during their lifetime, which could result in a loss or a substantial amount of unpaid principal and interest due upon maturity. First and second lien debt may also lose significant market value before a default occurs. Furthermore, an active trading market may not exist for these securities. This illiquidity may make it more difficult to value the investments.

Subordinated debt is generally subject to similar risks as those associated with first and second lien debt, except that such debt is subordinated in payment and/or lower in lien priority. Subordinated debt is subject to the additional risk that the cash flow of the borrower and the property securing the debt, if any, may be insufficient to meet scheduled payments after giving effect to the senior secured and unsecured obligations of the borrower.

The Company may directly invest in the equity of private companies or, in some cases, equity investments could be made in connection with a debt investment. Equity investments may or may not fluctuate in value, resulting in recognized realized gains or losses upon disposition.

Note 4. Fair Value

Pursuant to Rule 2a-5, a market quotation is readily available for purposes of Section 2(a)(41) of the 1940 Act with respect to a security only when that “quotation is a quoted price (unadjusted) in active markets for identical investments that the fund can access at the measurement date, provided that a quotation will not be readily available if it is not reliable.” Fair value is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a fair value hierarchy that prioritizes and ranks the inputs to valuation techniques used in measuring investments at fair value. The hierarchy classifies the inputs used in measuring fair value into three levels as follows:

Level I—Quoted prices (unadjusted) are available in active markets for identical investments and the Company has the ability to access such quotes as of the reporting date. The type of investments which would generally be included in Level I include active exchange-traded equity securities and exchange-traded derivatives. As required by ASC 820, the Company, to the extent that it holds such investments, does not adjust the quoted price for these investments, even in situations where the Company holds a large position and a sale could reasonably impact the quoted price.

Level II—Pricing inputs are observable for the investments, either directly or indirectly, as of the reporting date, but are not the same as those used in Level I. Level II inputs include the following:

Quoted prices for similar assets or liabilities in active markets;

Quoted prices for identical or similar assets or liabilities in non-active markets (examples include corporate and municipal bonds, which trade infrequently);

Pricing models whose inputs are observable for substantially the full term of the asset or liability (examples include most over-the-counter derivatives, including foreign exchange forward contracts); and

Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.

Level III—Pricing inputs are unobservable for the investment and include situations where there is little, if any, market activity for the investment.

The inputs used to measure fair value may fall into different levels. In all instances when the inputs fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level of input that is significant to the fair value measurement in its entirety. As such, a Level III fair value measurement may include inputs that are both observable and unobservable. Gains and losses for such assets categorized within the Level III table below may include changes in fair value that are attributable to both observable inputs and unobservable inputs.

The inputs into the determination of fair value require significant judgment or estimation by management and consideration of factors specific to each investment. A review of the fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in the transfer of certain investments within the fair value hierarchy from period to period.

The following table summarizes the levels in the fair value hierarchy that the Company’s portfolio investments fall into as of September 30, 2026:

TotalLevel ILevel IILevel III
First lien$1,430,905$—$56,490$1,374,415
Second lien68,064——68,064
Subordinated101,722——101,722
Structured Finance Obligations3,217——3,217
Equity and other656,054——656,054
Total investments$2,259,962$—$56,490$2,203,472

The following table summarizes the levels in the fair value hierarchy that the Company’s portfolio investments fall into as of December 31, 2025:

TotalLevel ILevel IILevel III
First lien$1,818,215$—$43,579$1,774,636
Second lien91,179——91,179
Subordinated121,487——121,487
Structured Finance Obligations3,277——3,277
Equity and other707,855——707,855
Total investments$2,742,013$—$43,579$2,698,434

The following table summarizes the changes in fair value of Level III portfolio investments for the three months ended September 30, 2026, as well as the portion of appreciation (depreciation) included in income attributable to the net change in unrealized appreciation (depreciation) related to those assets and liabilities still held by the Company at September 30, 2026:

TotalFirst LienSecond LienSubordinatedStructured Finance ObligationsEquity andother
Fair Value, June 30, 2026$2,229,035$1,394,174$72,991$98,429$3,191$660,250
Total gains or losses included in earnings:
Net realized gains (losses) on investments7880———(2)
Net change in unrealized (depreciation) appreciation of investments(14,477)(7,060)(2,582)(29)26(4,832)
Purchases, including capitalized PIK and revolver fundings35,60327,6786793,322—3,924
Proceeds from sales and paydowns of investments(1)(46,767)(40,457)(3,024)——(3,286)
Fair Value, September 30, 2026$2,203,472$1,374,415$68,064$101,722$3,217$656,054
Net change in unrealized (depreciation) appreciation for the period relating to those Level III assets that were still held by the Company at the end of the period:$(14,486)$(7,070)$(2,581)$(29)$27$(4,833)

The following table summarizes the changes in fair value of Level III portfolio investments for the three months ended September 30, 2025, as well as the portion of appreciation (depreciation) included in income attributable to the net change in unrealized appreciation (depreciation) related to those assets and liabilities still held by the Company at September 30, 2025:

TotalFirst LienSecond LienSubordinatedStructured Finance ObligationsEquity andother
Fair Value, June 30, 2025$2,920,263$1,927,366$128,623$107,986$3,249$753,039
Total gains or losses included in earnings:
Net realized gains (losses) on investments113(33)——41
Net change in unrealized (depreciation) appreciation of investments(19,504)(7,077)2,499(142)8(14,792)
Purchases, including capitalized PIK and revolver fundings139,332121,1739,4643,187—5,508
Proceeds from sales and paydowns of investments(163,342)(98,831)(62,656)——(1,855)
Transfers into Level III(1)20,231—20,231———
Transfers out of Level III(1)(54,257)(54,257)————
Fair Value, September 30, 2025$2,842,734$1,888,377$98,128$111,031$3,257$741,941
Net change in unrealized (depreciation) appreciation for the period relating to those Level III assets that were still held by the Company at the end of the period:$(37,652)$(7,387)$2,498$(143)$8$(32,628)

(1)As of September 30, 2025, portfolio investments were transferred into Level III from Level II and out of Level III into Level II at fair value as of the beginning of the quarterly period in which the reclassification occurred.

The following table summarizes the changes in fair value of Level III portfolio investments for the nine months ended September 30, 2026, as well as the portion of appreciation (depreciation) included in income attributable to the net change in unrealized appreciation (depreciation) related to those assets and liabilities still held by the Company at September 30, 2026:

TotalFirst LienSecond LienSubordinatedStructured Finance ObligationsEquity andother
Fair Value, December 31, 2025$2,698,434$1,774,636$91,179$121,487$3,277$707,855
Total gains or losses included in earnings:
Net realized losses on investments(75,554)(39,778)(7,956)(2,089)—(25,731)
Net change in unrealized (depreciation) appreciation of investments(13,500)(25,381)(176)(3,976)(60)16,093
Purchases, including capitalized PIK and revolver fundings264,176205,3523,54814,368—40,908
Proceeds from sales and paydowns of investments(1)(679,063)(558,527)(9,397)(25,313)—(85,826)
Transfers into Level III(2)(3)27,01818,1136,150——2,755
Transfers out of Level III(2)(3)(18,039)—(15,284)(2,755)——
Fair Value, September 30, 2026$2,203,472$1,374,415$68,064$101,722$3,217$656,054
Net change in unrealized depreciation for the period relating to those Level III assets that were still held by the Company at the end of the period:$(56,931)$(34,545)$(10,741)$(205)$(60)$(11,380)

(2)As of September 30, 2026, portfolio investments were transferred into Level III from Level II and out of Level III into Level II at fair value as of the beginning of the period in which the reclassification occurred.

(3)Includes reclassification of investment type to a claim.

The following table summarizes the changes in fair value of Level III portfolio investments for the nine months ended September 30, 2025, as well as the portion of appreciation (depreciation) included in income attributable to the net change in unrealized appreciation (depreciation) related to those assets and liabilities still held by the Company at September 30, 2025:

TotalFirst LienSecond LienSubordinatedStructured Finance ObligationsEquity andother
Fair Value, December 31, 2024$2,987,078$1,902,610$150,334$102,034$—$832,100
Total gains or losses included in earnings:
Net realized gains (losses) on investments51,087101(2,762)——53,748
Net change in unrealized (depreciation) appreciation of investments(98,823)(13,738)4,6733225(89,815)
Purchases, including capitalized PIK and revolver fundings(1)470,593365,52413,7198,965—82,385
Proceeds from sales and paydowns of investments(1)(550,437)(319,690)(94,270)——(136,477)
Transfers into Level III(2)29,666—26,434—3,232—
Transfers out of Level III(2)(46,430)(46,430)————
Fair Value, September 30, 2025$2,842,734$1,888,377$98,128$111,031$3,257$741,941
Net change in unrealized (depreciation) appreciation for the period relating to those Level III assets that were still held by the Company at the end of the period:$(53,505)$(13,964)$4,386$30$25$(43,982)

(2)As of September 30, 2025, portfolio investments were transferred into Level III from Level II and out of Level III into Level II at fair value as of the beginning of the period in which the reclassification occurred.

Except as noted in the tables above, there were no other transfers in or out of Levels I, II, or III during the three and nine months ended September 30, 2026 and September 30, 2025. Transfers into Level III occur as quotations obtained through pricing services are deemed not representative of fair value as of the balance sheet date and such assets are internally valued. As quotations obtained through pricing services are substantiated through additional market sources, investments are transferred out of Level III. In addition, transfers out of Level III and transfers into Level III occur based on the increase or decrease in the availability of certain observable inputs.

The Company invests in revolving credit facilities. These investments are generally categorized as Level III investments as these assets are not actively traded and their fair values are often implied by the term loans of the respective portfolio companies.

The Company generally uses the following framework when determining the fair value of investments where there is little, if any, market activity or observable pricing inputs. The Company typically determines the fair value of its performing debt investments utilizing an income approach. Additional consideration is given using a market based approach, as well as reviewing the overall underlying portfolio company's performance and associated financial risks. The following outlines additional details on the approaches considered:

Company Performance, Financial Review, and Analysis: Prior to investment, as part of its due diligence process, the Company evaluates the overall performance and financial stability of the portfolio company. Post investment, the Company analyzes each portfolio company's current operating performance and relevant financial trends versus prior year and budgeted results, including, but not limited to, factors affecting its revenue and earnings before interest, taxes, depreciation, and amortization ("EBITDA") growth, margin trends, liquidity position, covenant compliance and changes to its capital structure. The Company also attempts to identify and subsequently track any developments at the portfolio company, within its customer or vendor base or within the industry or the macroeconomic environment, generally, that may alter any material element of its original investment thesis. This analysis is specific to each portfolio company. The Company leverages the knowledge gained from its original due diligence process, augmented by this subsequent monitoring, to continually refine its outlook for each of its portfolio companies and ultimately form the valuation of its investment in each portfolio company. When an external event such as a purchase transaction, public offering or subsequent sale occurs, the Company will consider the pricing indicated by the external event to corroborate the private valuation.

For debt investments, the Company may employ the Market Based Approach (as described below) to assess the total enterprise value of the portfolio company, in order to evaluate the enterprise value coverage of the Company’s debt investment. For equity investments or in cases where the Market Based Approach implies a lack of enterprise value coverage for the debt investment, the Company may additionally employ a discounted cash flow analysis based on the free cash flows of the portfolio company to assess the total enterprise value. After enterprise value coverage is demonstrated for the Company’s debt investments through the method(s) above, the Income Based Approach (as described below) may be employed to estimate the fair value of the investment.

Market Based Approach: The Company may estimate the total enterprise value of each portfolio company by utilizing EBITDA or revenue multiples of publicly traded comparable companies and comparable transactions. The Company considers numerous factors when selecting the appropriate companies whose trading multiples are used to value its portfolio companies. These factors include, but are not limited to, the type of organization, similarity to the business being valued, and relevant risk factors, as well as size, profitability and growth expectations. The Company may apply an average of various relevant comparable company EBITDA or revenue multiples to the portfolio company's latest twelve month ("LTM") EBITDA or revenue or projected EBITDA or revenue to calculate the enterprise value of the portfolio company. Significant increases or decreases in the EBITDA or revenue multiple will result in an increase or decrease in enterprise value, which may result in an increase or decrease in the fair value estimate of the investment. In applying the market based approach as of September 30, 2026 and December 31, 2025, the Company used the relevant EBITDA or revenue multiple ranges set forth in the table below to determine the enterprise value of its portfolio companies. The Company believes these were reasonable ranges in light of current comparable company trading levels and the specific portfolio companies involved.

Income Based Approach: The Company also may use a discounted cash flow analysis to estimate the fair value of the investment. Projected cash flows represent the relevant security's contractual interest, fee and principal payments plus the assumption of full principal recovery at the investment's expected maturity date. These cash flows are discounted at a rate established utilizing a combination of a yield calibration approach and a comparable investment approach. The yield calibration approach incorporates changes in the credit quality (as measured by relevant statistics) of the portfolio company, as compared to changes in the yield associated with comparable credit quality market indices, between the date of origination and the valuation date. The comparable investment approach utilizes an average yield-to-maturity of a selected set of high-quality, liquid investments to determine a comparable investment discount rate. Significant increases or decreases in the discount rate would result in a decrease or increase in the fair value measurement. In applying the income based approach as of September 30, 2026 and December 31, 2025, the Company used the discount ranges set forth in the table below to value investments in its portfolio companies.

The unobservable inputs used in the fair value measurement of the Company's Level III investments as of September 30, 2026 were as follows:

Range
Type · Fair Value as of September 30, 2026 · Approach · Unobservable Input · Low · High · WeightedAverage(1)
First lien$1,305,037Market & Income ApproachEBITDA multiple4.0x22.0x12.8x
Revenue multiple · 1.0x · 10.5x · 7.5x
Discount rate7.4%66.0%11.7%
69,378OtherN/A(2)N/AN/AN/A
Second lien68,064Market & Income ApproachEBITDA multiple10.0x20.5x20.2x
Discount rate11.8%28.7%19.7%
Subordinated101,722Market & Income ApproachEBITDA multiple7.5x20.0x12.8x
Discount rate13.4%19.8%17.1%
Structured Finance Obligations3,217Income ApproachDiscount rate11.3%11.3%11.3%
Equity and other277,421Market & Income ApproachEBITDA multiple6.0x28.0x11.0x
Discount rate10.0%29.0%15.1%
378,633Income ApproachDiscount rate6.2%14.0%10.8%
$2,203,472

(1)Unobservable inputs were weighted by the relative fair value of the investments.

(2)Fair value was determined based on transaction pricing, recent acquisition or sale as the best measure of fair value with no material changes in operations of the related portfolio company since the transaction date.

The unobservable inputs used in the fair value measurement of the Company's Level III investments as of December 31, 2025 were as follows:

Range
Type · Fair Value as of December 31, 2025 · Approach · Unobservable Input · Low · High · WeightedAverage(1)
First lien$1,765,624Market & Income ApproachEBITDA multiple5.0x31.3x14.3x
Revenue multiple · 4.0x · 19.5x · 10.3x
Discount rate6.1%21.6%9.1%
9,012OtherN/A(2)N/AN/AN/A
Second lien84,722Market & Income ApproachEBITDA multiple14.0x18.0x16.0x
Discount rate9.4%15.8%13.5%
6,457OtherN/A(2)N/AN/AN/A
Subordinated121,487Market & Income ApproachEBITDA multiple7.0x20.0x13.4x
Discount rate11.7%18.9%14.1%
Structured Finance Obligations3,277Income ApproachDiscount rate10.5%10.5%10.5%
Equity and other320,328Market & Income ApproachEBITDA multiple5.5x21.7x11.7x
Revenue multiple · 8.5x · 10.5x · 9.0x
Discount rate9.3%20.2%11.7%
387,527Income ApproachDiscount rate6.3%15.7%11.4%
$2,698,434

(1)Unobservable inputs were weighted by the relative fair value of the investments.

(2)Fair value was determined based on transaction pricing or recent acquisition or sale as the best measure of fair value with no material changes in operations of the related portfolio company since the transaction date.

The carrying value of the claim related to a collateralized agreement approximates fair value as of September 30, 2026 and is considered a Level III investment. The fair value of other financial assets and liabilities approximates their carrying value based on the short-term nature of these items.

The June 2027 Notes, Holdings Credit Facility, SBA-guaranteed debentures and NMFC Credit Facility and, as of December 31, 2025, the January 2026 Notes, are considered Level III securities. The fair values of the November 2028 Notes, the February 2029 Notes and the October 2027 Notes are based on quoted prices and are considered Level II securities. See Note 7. Borrowings, for details.

The following are the principal amounts and fair values of the Company’s borrowings as of September 30, 2026 and December 31, 2025. Fair value is estimated by discounting remaining payments using applicable current market rates, which take into account changes in the Company’s marketplace credit ratings or market quotes, if available.

As of
September 30, 2026December 31, 2025
Principal AmountFair ValuePrincipal AmountFair Value
Unsecured Notes$790,000$790,775$990,000$1,002,356
Holdings Credit Facility391,446389,677420,063419,981
SBA-guaranteed debentures120,00097,963196,205175,141
NMFC Credit Facility (1)30,21230,27881,07481,097
Total Borrowings$1,331,658$1,308,693$1,687,342$1,678,575

(1) As of September 30, 2026, the principal amount of the NMFC Credit Facility was $30,212, which included €16,512 denominated in EUR and £8,666 denominated in GBP that has been translated to U.S. dollars. As of September 30, 2026, the fair value of the NMFC Credit Facility was $30,278, which included €16,547 denominated in EUR and £8,686 denominated in GBP that has been translated to U.S. dollars. As of December 31, 2025, the principal amount of the NMFC Credit Facility was $81,074, which included €16,512 denominated in EUR and £8,666 denominated in

GBP that has been translated to U.S. dollars. As of December 31, 2025, the fair value of the NMFC Credit Facility was $81,097, which included €16,479 denominated in EUR and £8,651 denominated in GBP that has been translated to U.S. dollars.

The following table summarizes the notional amounts and fair values of the Company's derivative instruments as of September 30, 2026 and December 31, 2025. The Company's derivative instruments are considered Level II investments.

As of September 30, 2026 · As of December 31, 2025
Notional Amount · Fair Value · Notional Amount · Fair Value
Asset · Liability · Asset · Liability
Derivatives in fair value hedging relationships:
Interest rate swaps$600,000$—$(9,296)$600,000$5,647$(366)
Total derivatives designated as hedging instruments600,000—(9,296)600,0005,647(366)
Total derivatives600,000—(9,296)600,0005,647(366)
Total net derivatives(1)$600,000$—$(9,296)$600,000$5,281$—

(1)As of September 30, 2026, the Company had a net derivative liability at fair value subject to such enforceable master netting arrangement in the amount of $9,296 and a collateral balance of $60, included in "Receivable from broker" on the Consolidated Statements of Assets and Liabilities. As of December 31, 2025, the Company had a net derivative asset at fair value subject to such enforceable master netting arrangement in the amount of $5,281 and a collateral balance of $14,630, included in "Payable to broker" on the Consolidated Statements of Assets and Liabilities. As of September 30, 2026 and December 31, 2025, if the Company had elected to offset, the net amount would be $9,236 and $0, respectively.

Fair value risk factors—The Company seeks investment opportunities that offer the possibility of attaining substantial capital appreciation. Certain events particular to each industry in which the Company's portfolio companies conduct their operations, as well as general economic, political and public health conditions, may have a significant negative impact on the operations and profitability of the Company's investments and/or on the fair value of the Company's investments. The Company's investments are subject to the risk of non-payment of scheduled interest or principal, resulting in a reduction in income to the Company and their corresponding fair valuations. Also, there may be risk associated with the concentration of investments in one geographic region or in certain industries. These events are beyond the control of the Company and cannot be predicted. Furthermore, the ability to liquidate investments and realize value is subject to uncertainties.

Note 5. Agreements

The Company entered into an investment advisory and management agreement (as amended from time to time, the “Investment Management Agreement”) with the Investment Adviser, which was most recently re-approved by the Company's board of directors on February 11, 2026, for a period of 12 months commencing on March 1, 2026. Under the Investment Management Agreement, the Investment Adviser manages the day-to-day operations of, and provides investment advisory services to, the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting oftwo components—a base management fee and an incentive fee. On November 1, 2021, the Company entered into Amendment No. 1 to the Investment Management Agreement (“Amendment No. 1”). As described below, the sole purpose of Amendment No. 1 was to reduce the base management fee from 1.75% of the Company’s gross assets to 1.4% of the Company’s gross assets. On January 29, 2025, the Company entered into Amendment No. 2 to the Investment Management Agreement ("Amendment No. 2"), the sole purpose of which was to reduce the base management fee from 1.4% of the Company's gross assets to 1.25% of the Company's gross assets.

Pursuant to Amendment No. 1, prior to January 29, 2025, the base management fee was calculated at an annual rate of 1.4% of the Company's gross assets, which equals the Company's total assets on the Consolidated Statements of Assets and Liabilities, less cash and cash equivalents. Pursuant to Amendment No. 2, as of January 29, 2025, the base management fee is calculated at an annual rate of 1.25% of the Company's gross assets. The base management fee is payable quarterly in arrears, and is calculated based on the average value of the Company's gross assets, which equals the Company's total assets, as determined in accordance with GAAP, less cash and cash equivalents at the end of each of the two most recently completed calendar quarters, and appropriately adjusted on a pro rata basis for any equity capital raises or repurchases during the current calendar quarter. To the extent the Company invests in derivatives, the Company uses the actual value of the derivatives, as reported on the Consolidated Statements of Assets and Liabilities, for purposes of calculating its base management fee.

The Company entered into a fee waiver agreement (the "Fee Waiver Agreement"), dated March 31, 2021, as subsequently amended on November 2, 2021 and August 3, 2023, pursuant to which, effective as of and for the quarter ended

March 31, 2021 through the quarter ended December 31, 2024, the Investment Adviser waived base management fees in order to reach a target base management fee of 1.25% on gross assets. Following the expiration of the Fee Waiver Agreement on December 31, 2024, the Investment Adviser agreed to waive an amount of the base management fee that it may have been entitled to under the Investment Management Agreement for the period of January 1, 2025 through January 28, 2025, that would be in excess of an annual rate of 1.25% of the Company's gross assets. The Investment Adviser cannot recoup management fees that the Investment Adviser has previously waived. For the three and nine months ended September 30, 2026, no management fees were waived. For the three and nine months ended September 30, 2025, management fees waived were $0 and approximately $288, respectively.

The incentive fee consists oftwo parts. The first part is calculated and payable quarterly in arrears and equals 20.0% of the Company’s “Pre-Incentive Fee Net Investment Income” for the immediately preceding quarter, subject to a “preferred return”, or “hurdle”, and a “catch-up” feature. “Pre-Incentive Fee Net Investment Income” means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, upfront, diligence and consulting fees or other fees that the Company receives from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under an administration agreement, as amended and restated (the “Administration Agreement”), with the Administrator, and any interest expense and distributions paid on any issued and outstanding preferred stock (of which there were none as of September 30, 2026), but excluding the incentive fee). Pre-Incentive Fee Net Investment Income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation.

Pre-Incentive Fee Net Investment Income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, will be compared to a "hurdle rate" of 2.0% per quarter (8.0% annualized), subject to a "catch-up" provision measured as of the end of each calendar quarter. The hurdle rate is appropriately pro-rated for any partial periods. The calculation of the Company’s incentive fee with respect to the Pre-Incentive Fee Net Investment Income for each quarter is as follows:

No incentive fee is payable to the Investment Adviser in any calendar quarter in which the Company’s Pre-Incentive Fee Net Investment Income does not exceed the hurdle rate of 2.0% (the "preferred return" or "hurdle").

100.0% of the Company’s Pre-Incentive Fee Net Investment Income with respect to that portion of such Pre-Incentive Fee Net Investment Income, if any, that exceeds the hurdle rate but is less than or equal to 2.5% in any calendar quarter (10.0% annualized) is payable to the Investment Adviser. This portion of the Company’s Pre-Incentive Fee Net Investment Income (which exceeds the hurdle rate but is less than or equal to 2.5%) is referred to as the "catch-up". The catch-up provision is intended to provide the Investment Adviser with an incentive fee of 20.0% on all of the Company’s Pre-Incentive Fee Net Investment Income as if a hurdle rate did not apply when the Company's Pre-Incentive Fee Net Investment Income exceeds 2.5% in any calendar quarter.

20.0% of the amount of the Company’s Pre-Incentive Fee Net Investment Income, if any, that exceeds 2.5% in any calendar quarter (10.0% annualized) is payable to the Investment Adviser once the hurdle is reached and the catch-up is achieved.

The Investment Adviser can voluntarily agree to waive a portion of the incentive fee that would otherwise have been earned during the period. The incentive fee waiver is made at the sole discretion of the Investment Adviser and is not required by any contractual or regulatory obligation. For the three and nine months ended September 30, 2026, incentive fees waived were approximately $1,387 and $8,932, respectively. For the three and nine months ended September 30, 2025, incentive fees waived were approximately $4,544 and $8,664, respectively.

The second part of the incentive fee will be determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Management Agreement) and will equal 20.0% of the Company’s realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee.

In accordance with GAAP, the Company accrues a hypothetical capital gains incentive fee based upon the cumulative net realized capital gains and realized capital losses and the cumulative net unrealized capital appreciation and unrealized capital depreciation on investments held at the end of each period. Actual amounts paid to the Investment Adviser are consistent with the Investment Management Agreement and are based only on actual realized capital gains computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis from inception through the end of each calendar year.

The following table summarizes the management fees and incentive fees incurred by the Company for the three and nine months ended September 30, 2026 and September 30, 2025:

Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Management fee$7,312$9,619$22,880$29,611
Less: management fee waiver———(288)
Total net management fee7,3129,61922,88029,323
Incentive fee, excluding accrued capital gains incentive fees5,5487,34517,41723,563
Less: incentive fee waiver(1,387)(4,544)(8,932)(8,664)
Total net incentive fee$4,161$2,801$8,485$14,899
Accrued capital gains incentive fees(1)$—$—$—$—

(1)As of September 30, 2026 and September 30, 2025, no actual capital gains incentive fee was owed under the Investment Management Agreement by the Company, as cumulative net realized capital gains did not exceed cumulative unrealized capital depreciation.

The Company has entered into the Administration Agreement with the Administrator under which the Administrator provides administrative services. The Administration Agreement was most recently re-approved by the Company's board of directors on February 11, 2026 for a period of 12 months commencing on March 1, 2026. The Administrator maintains, or oversees the maintenance of, the Company’s consolidated financial records, prepares reports filed with the SEC, generally monitors the payment of the Company's expenses and oversees the performance of administrative and professional services rendered by others. The Company reimburses the Administrator for the Company's allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations to the Company under the Administration Agreement. Pursuant to the Administration Agreement and further restricted by the Company, the Administrator may, in its own discretion, submit to the Company for reimbursement some or all of the expenses that the Administrator has incurred on behalf of the Company during any quarterly period. As a result, the amount of expenses for which the Company will have to reimburse the Administrator may fluctuate in future quarterly periods and there can be no assurance given as to when, or if, the Administrator may determine to limit the expenses that the Administrator submits to the Company for reimbursement in the future. However, it is expected that the Administrator will continue to support part of the expense burden of the Company in the near future and may decide to not calculate and charge through certain overhead related amounts as well as continue to cover some of the indirect costs. The Administrator cannot recoup any expenses that the Administrator has previously waived. For the three and nine months ended September 30, 2026, approximately $465 and$1,621, respectively, of indirect administrative expenses were included in administrative expenses, of whichno expenses were waived by the Administrator. For the three and nine months ended September 30, 2025, approximately $599 and$1,944, respectively, of indirect administrative expenses were included in administrative expenses, of whichno expenses were waived by the Administrator. As of September 30, 2026 and December 31, 2025, approximately $555 and $610, respectively, of indirect administrative expenses were included in payable to (receivable from) affiliates. For the three and nine months ended September 30, 2026, the reimbursement to the Administrator represented approximately 0.02% and 0.07%, respectively, of the Company's gross assets. For the three and nine months ended September 30, 2025, the reimbursement to the Administrator represented approximately 0.02% and 0.06%, respectively, of the Company's gross assets.

The Company, the Investment Adviser and the Administrator have also entered into a Trademark License Agreement, as amended, with New Mountain Capital, pursuant to which New Mountain Capital has agreed to grant the Company, the Investment Adviser and the Administrator a non-exclusive, royalty-free license to use the "New Mountain" and the "New Mountain Finance" names, as well as the NMF logo. Under the Trademark License Agreement, as amended, subject to certain conditions, the Company, the Investment Adviser and the Administrator will have a right to use the "New Mountain" and "New Mountain Finance" names, as well as the NMF logo, for so long as the Investment Adviser or one of its affiliates remains the investment adviser of the Company. Other than with respect to this limited license, the Company, the Investment Adviser and the Administrator will have no legal right to the "New Mountain" or the "New Mountain Finance" names, as well as the NMF logo.

Note 6. Related Parties

The Company has entered into a number of business relationships with affiliated or related parties.

The Company has entered into the Investment Management Agreement with the Investment Adviser, a wholly-owned subsidiary of New Mountain Capital. Therefore, New Mountain Capital is entitled to any profits earned by the Investment Adviser, which includes any fees payable to the Investment Adviser under the terms of the Investment Management Agreement, less expenses incurred by the Investment Adviser in performing its services under the Investment Management Agreement.

The Company has entered into the Fee Waiver Agreement with the Investment Adviser, pursuant to which the Investment Adviser originally agreed to voluntarily reduce the base management fees payable to the Investment Adviser by the Company under the Investment Management Agreement beginning with the quarter ended March 31, 2021 through the quarter ended December 31, 2022. Subsequently, the Company and the Investment Adviser extended the term of the Fee Waiver Agreement to be effective through the quarter ended December 31, 2024. Following the expiration of the Fee Waiver Agreement, the Investment Adviser agreed to waive an amount of the base management fee that it may have been entitled to under the Investment Management Agreement for the period of January 1, 2025 through January 28, 2025, that would be in excess of an annual rate of 1.25% of the Company's gross assets. See Note 5. Agreements, for details.

The Company has entered into the Administration Agreement with the Administrator, a wholly-owned subsidiary of New Mountain Capital. The Administrator arranges office space for the Company and provides office equipment and administrative services necessary to conduct their respective day-to-day operations pursuant to the Administration Agreement. The Company reimburses the Administrator for the allocable portion of overhead and other expenses incurred by it in performing its obligations to the Company under the Administration Agreement, which includes the fees and expenses associated with performing administrative, finance and compliance functions, and the compensation of the Company's chief financial officer and chief compliance officer and their respective staffs.

The Company, the Investment Adviser and the Administrator have entered into a royalty-free Trademark License Agreement, as amended, with New Mountain Capital, pursuant to which New Mountain Capital has agreed to grant the Company, the Investment Adviser and the Administrator a non-exclusive, royalty-free license to use the name "New Mountain" and "New Mountain Finance", as well as the NMF logo.

The Company has adopted a formal code of ethics that governs the conduct of its officers and directors. These officers and directors also remain subject to the duties imposed by the 1940 Act and the Delaware General Corporation Law.

The Investment Adviser and its affiliates may also manage other funds in the future that may have investment mandates that are similar, in whole or in part, to the Company’s investment mandates. The Investment Adviser and its affiliates may determine that an investment is appropriate for the Company or for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that the Company should invest side-by-side with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff and consistent with the Investment Adviser’s allocation procedures. The Company may be prohibited under the 1940 Act from participating in certain transactions with its affiliates without prior approval of the directors who are not interested persons, and in some cases, the prior approval of the SEC. The Investment Adviser and certain of its affiliates were granted an order for exemptive relief that permitted co-investing with affiliates of the Company subject to various approvals of the board of directors and other conditions. On May 13, 2025, the Company, the Investment Adviser and certain of their affiliates were granted a new order for exemptive relief that superseded the prior order for exemptive relief (the “Exemptive Order”) by the SEC for the Company to co-invest with other funds managed by the Investment Adviser or certain affiliates pursuant to the conditions of the Exemptive Order. Pursuant to such Exemptive Order, the Company generally is permitted to co-invest with certain of its affiliates if such co-investments are done on the same terms and at the same time, as further detailed in the Exemptive Order. The Exemptive Order requires that a “required majority” (as defined in Section 57(o) of the 1940 Act) of the board of directors make certain findings (1) in most instances when the Company co-invests with its affiliates in an issuer where an affiliate of the Company has an existing investment in the issuer, and (2) if the Company disposes of an asset acquired in a transaction under the Exemptive Order unless the disposition is done on a pro rata basis, or is a sale of a tradable security. Pursuant to the Exemptive Order, the board of directors will oversee the Company’s participation in the co-investment program. As required by the Exemptive Order, the Company has adopted, and the board of directors has approved, policies and procedures reasonably designed to ensure compliance with the terms of the Exemptive Order, and the Investment Adviser and the Company’s Chief Compliance Officer will provide reporting to the board of directors.

On March 30, 2020, an affiliate of the Investment Adviser purchased directly from NMNLC 105,030 shares of NMNLC’s common stock at a price of $107.73 per share, which represented the net asset value per share of NMNLC at the date of purchase, for an aggregate purchase price of approximately $11,315. Immediately thereafter, NMNLC redeemed 105,030 shares of its common stock held by the Company in exchange for a promissory note with a principal amount of $11,315 and a 7.0% interest rate, which was repaid by NMNLC to the Company on March 31, 2020. Effective July 1, 2024, NMNLC purchased 63,575 shares of NMNLC's common stock from an affiliate of the Investment Adviser at remaining original cost, a price of $73.39 per share, for an aggregate purchase price of approximately $4,666. Immediately thereafter, NMNLC sold the 63,575 shares of its common stock to NMFC at remaining original cost, a price of $73.39 per share, for an aggregate purchase price of approximately $4,666.

On March 30, 2020, the Company entered into an unsecured revolving credit facility with NMF Investments III, L.L.C., an affiliate of the Investment Adviser, with a $30,000 maximum amount of revolver borrowings available and a maturity date of December 31, 2022. On May 4, 2020, the Company entered into an Amended and Restated Uncommitted Revolving Loan Agreement with NMF Investments III, L.L.C. (the "Uncommitted Revolving Loan Agreement" and the facility thereunder, the "Unsecured Management Company Revolver"), which increased the maximum amounts of revolving borrowings available thereunder from $30,000 to $50,000. On October 31, 2023, the Company entered into a Second Amended and Restated Uncommitted Revolving Loan Agreement with NMF Investments III, L.L.C., which increased the maximum amounts of revolving borrowings thereunder from $50,000 to $100,000, extended the maturity date from December 31, 2024 to December 31, 2027 and changed the interest rate to the Applicable Federal Rate (as defined in the Uncommitted Revolving Loan Agreement). On October 27, 2025, the Company entered into the Third Amended and Restated Uncommitted Revolving Loan Agreement which extended the maturity date from December 31, 2027 to December 31, 2030. Refer to Note 7. Borrowings for discussion of the Unsecured Management Company Revolver (defined above).

NMFC and SBIC I are parties to an intercompany promissory note (the "Intercompany Note"). The purpose of the Intercompany Note is to fund the repayment of the SBA-guaranteed debentures issued by SBIC I. Under the terms of the Intercompany Note, no fees or interest are payable to NMFC. For the purposes of the consolidated financial statements, all balances and transactions related to the Intercompany Note are eliminated. As of September 30, 2026 and December 31, 2025, the Intercompany Note had a principal balance of $51,200 and $43,700, respectively.

Note 7. Borrowings

On June 8, 2018, the Company's stockholders approved the application of the modified asset coverage requirements set forth in Section 61(a) of the 1940 Act, which resulted in the reduction of the minimum asset coverage ratio applicable to the Company from 200.0% to 150.0% as of June 9, 2018 (which means the Company can borrow $2 for every $1 of its equity). As a result of the Company's exemptive relief received on November 5, 2014, the Company is permitted to exclude the SBA-guaranteed debentures issued by SBIC I, SBIC II and SBIC III, if any, from the definition of "senior security" for the 150.0% asset coverage ratio that the Company is required to maintain under the 1940 Act. The agreements governing the NMFC Credit Facility and certain of the Unsecured Notes (as defined below) contain certain covenants and terms, including a requirement that the Company not exceed a debt-to-equity ratio of 1.65 to 1.00 at the time of incurring additional indebtedness and a requirement that the Company not exceed a secured debt ratio of 0.70 to 1.00 at any time. As of September 30, 2026, the Company’s asset coverage ratio was 184.03%.

Holdings Credit Facility—On October 24, 2017, the Company entered into the Third Amended and Restated Loan and Security Agreement (as amended from time to time, the "Loan and Security Agreement") among the Company, as the Collateral Manager, NMF Holdings, as the Borrower, Wells Fargo Securities, LLC, as the Administrative Agent and Wells Fargo Bank, National Association, as the Lender and Collateral Custodian (the "Holdings Credit Facility"). As of the amendment on March 12, 2026, the maturity date of the Holdings Credit Facility is March 12, 2031, and the maximum facility amount is the lesser of the actual commitments of the lenders to make advances as of such date and the commitment amount. As of the amendment on March 12, 2026, the commitment amount is $450,000 from March 12, 2026 to October 26, 2026 and $350,000 from October 26, 2026 to March 12, 2031. On October 2, 2026, the Company elected to reduce the commitment amount to $350,000 in advance of the scheduled October 26, 2026 reduction date.

As of September 30, 2026, the maximum amount of revolving borrowings available under the Holdings Credit Facility is $450,000. Under the Holdings Credit Facility, NMF Holdings is permitted to borrow up to 35.0%,45.0%,55.0%,67.5% or 70.0% of the purchase price of pledged assets, subject to approval by Wells Fargo Bank, National Association. The Holdings Credit Facility is non-recourse to the Company and is collateralized by all of the investments of NMF Holdings on an investment by investment basis. All fees associated with the origination, amending or upsizing of the Holdings Credit Facility are capitalized on the Company's Consolidated Statements of Assets and Liabilities and charged against income as other financing expenses over the life of the Holdings Credit Facility. The Holdings Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Holdings Credit Facility requires the Company to maintain a minimum asset coverage ratio of 150.0%. The covenants are generally not tied to mark to market fluctuations in the prices of NMF Holdings investments, but rather to the performance of the underlying portfolio companies.

As of the amendment on March 12, 2026, the Holdings Credit Facility bears interest at a rate of SOFR plus 1.85% per annum. From March 28, 2025 to March 11, 2026, the Holdings Credit Facility bore interest at a rate of SOFR plus 1.95% per annum. From July 29, 2024 to March 27, 2025, the Holdings Credit Facility bore interest at a rate of SOFR plus 2.15% per annum. The Holdings Credit Facility also charges a non-usage fee, based on the unused facility amount multiplied by the Non-Usage Fee Rate (as defined in the Loan and Security Agreement).

The following table summarizes the interest expense, non-usage fees and amortization of financing costs incurred on the Holdings Credit Facility for the three and nine months ended September 30, 2026 and September 30, 2025:

Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Interest expense$5,048$4,726$16,698$13,741
Non-usage fee$115$557$483$1,865
Amortization of financing costs$660$677$3,372$1,921
Weighted average interest rate5.5%6.3%5.5%6.4%
Effective interest rate6.4%8.0%6.9%8.2%
Average debt outstanding$359,174$293,932$398,377$285,184

As of September 30, 2026 and December 31, 2025, the outstanding balance on the Holdings Credit Facility was $391,446 and $420,063, respectively, and NMF Holdings was in compliance with the applicable covenants of the Holdings Credit Facility on such dates.

NMFC Credit Facility—The Second Amended and Restated Senior Secured Revolving Credit Agreement (as amended from time to time, and together with the related guarantee and security agreement, the "RCA"), dated September 30, 2024, among the Company, as the Borrower, Sumitomo Mitsui Banking Corporation, as the Administrative Agent, and the Lenders, as outlined in the RCA (the "NMFC Credit Facility"), is structured as a senior secured revolving credit facility. The NMFC Credit Facility is guaranteed by certain of the Company's domestic subsidiaries and proceeds from the NMFC Credit Facility may be used for general corporate purposes, including the funding of portfolio investments. As of the amendment on July 30, 2026, the maturity date for the Extending Lenders (as defined in the RCA) of the NMFC Credit Facility is July 30, 2031 and the maturity date for Non-Extending Lenders (as defined in the RCA) is September 28, 2029.

As of the amendment on July 30, 2026, the maximum amount of revolving borrowings available under the NMFC Credit Facility is $537,100, of which $487,100 had been committed by Extending Lenders and $50,000 had been committed by Non-Extending Lenders. Prior to the amendment on July 30, 2026, the maximum amount of revolving borrowings available under the NMFC Credit Facility was $527,100. The Company is permitted to borrow at various advance rates depending on the type of portfolio investment, as outlined in the RCA. All fees associated with the origination and amending of the NMFC Credit Facility are capitalized on the Company’s Consolidated Statements of Assets and Liabilities and charged against income as other financing expenses over the life of the NMFC Credit Facility. The NMFC Credit Facility contains certain customary affirmative and negative covenants and events of default, including certain financial covenants related to asset coverage and liquidity and other maintenance covenants.

As of the amendment on July 30, 2026, the NMFC Credit Facility generally bears interest at a rate of SOFR, SONIA or EURIBOR, plus any applicable credit spread adjustment, plus either 1.90% per annum or 2.00% per annum, depending on the terms outlined in the amendment, and charges a commitment fee, based on the unused facility amount multiplied by 0.375% per annum (as defined in the RCA). From September 30, 2024 to July 29, 2026, the NMFC Credit Facility generally bore interest at a rate of SOFR, SONIA or EURIBOR, plus any applicable credit spread adjustment, plus 1.90% per annum or 2.10% per annum, subject to the terms outlined in the RCA, and charged a commitment fee, based on the unused facility amount multiplied by 0.375% per annum (as defined in the RCA). As of the amendment on June 5, 2024, the Canadian Dollar Offered Rate was replaced with the Canadian Overnight Repo Rate Average term rate plus a credit spread adjustment as a benchmark rate for certain assets.

The following table summarizes the interest expense, non-usage fees and amortization of financing costs incurred on the NMFC Credit Facility for the three and nine months ended September 30, 2026 and September 30, 2025:

Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Interest expense$371$390$2,248$1,149
Non-usage fee$482$476$1,340$1,563
Amortization of financing costs$223$189$633$560
Weighted average interest rate4.8%4.7%5.1%5.0%
Effective interest rate13.9%13.5%9.7%14.6%
Average debt outstanding$30,658$30,991$58,155$29,879

As of September 30, 2026, the outstanding balance on the NMFC Credit Facility was $30,212, which included €16,512 denominated in Euro ("EUR") and £8,666 denominated in British Pound Sterling ("GBP") that has been translated to U.S. dollars. As of December 31, 2025, the outstanding balance on the NMFC Credit Facility was $81,074, which included €16,512 denominated in EUR and £8,666 denominated in GBP that has been translated to U.S. dollars.

Unsecured Management Company Revolver—The Unsecured Management Company Revolver is structured as a discretionary unsecured revolving credit facility. The proceeds from the Unsecured Management Company Revolver may be used for general corporate purposes, including the funding of portfolio investments. As of the amendment on October 27, 2025, the maturity date of the Unsecured Management Company Revolver is December 31, 2030.

As of the amendment on October 31, 2023, the Unsecured Management Company Revolver bears interest at the Applicable Federal Rate. As of September 30, 2026, the maximum amount of revolving borrowings available under the Unsecured Management Company Revolver was $100,000 andno borrowings were outstanding. For the three and nine months ended September 30, 2026, amortization of financing costs was $1 and $4, respectively. For the three and nine months ended September 30, 2025, amortization of financing costs was $1 and $3, respectively.

2022 Convertible Notes— On November 2, 2022, the Company closed a private offering of $200,000 aggregate principal amount of unsecured convertible notes (the “2022 Convertible Notes”), pursuant to an indenture, dated August 20, 2018, as supplemented by a third supplemental indenture thereto, dated November 2, 2022 (together the “2018C Indenture”). On March 14, 2023, the Company issued an additional $60,000 aggregate principal amount of the 2022 Convertible Notes. These additional 2022 Convertible Notes constitute a further issuance of, rank equally in right of payment with, and form a single series with the $200,000 aggregate principal amount of the 2022 Convertible Notes that the Company issued in November 2022.

On January 21, 2025, the Company launched a tender offer to purchase, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated January 21, 2025, up to $260,000 aggregate principal amount of the outstanding 2022 Convertible Notes for cash in an amount equal to $1.01 per $1.00 principal amount of Notes purchased (exclusive of accrued and unpaid interest on such notes) (the "2022 Convertible Notes Tender Offer"). The 2022 Convertible Notes Tender Offer expired on February 19, 2025. As of the expiration of the 2022 Convertible Notes Tender Offer, $1,216 aggregate principal amount of the 2022 Convertible Notes were validly tendered and not validly withdrawn pursuant to the 2022 Convertible Notes Tender Offer. The Company accepted for purchase all of the 2022 Convertible Notes that were validly tendered and not validly withdrawn at the expiration of the 2022 Convertible Notes Tender Offer. Following settlement of the 2022 Convertible Notes Tender Offer on February 24, 2025, approximately $258,784 aggregate principal amount of the 2022 Convertible Notes remained outstanding. On June 27, 2025, the Company was notified that $7 of aggregate principal amount of the 2022 Convertible Notes were being converted to 514 shares of common stock at a conversion price of $13.61 per share, with the transaction settling on July 2, 2025.

The 2022 Convertible Notes matured on October 15, 2025, pursuant to the terms of the 2018C Indenture. The Company could not redeem the 2022 Convertible Notes prior to July 15, 2025. Prior to their maturity, on or after July 15, 2025, the 2022 Convertible Notes were redeemable for cash, in whole or from time to time in part, at the Company's option at a redemption price, subject to an exception for redemption dates occurring after a record date but on or prior to the interest payment date, equal to the sum of (i)100% of the principal amount of the 2022 Convertible Notes to be redeemed, (ii) accrued and unpaid interest thereon to, but excluding, the redemption date and (iii) a make-whole premium.

Prior to the maturity of the 2022 Convertible Notes, the conversion rate was subject to adjustment upon certain events, such as stock splits and combinations, mergers, spin-offs, increases in dividends in excess of $0.30 per share per quarter for the 2022 Convertible Notes and certain changes in control. Certain of these adjustments, including adjustments for increases in dividends, were subject to a conversion price floor of $12.38 per share for the 2022 Convertible Notes. In no event would the total number of shares of common stock issuable upon conversion exceed 80.7754 per $1 principal amount of the 2022 Convertible Notes. The Company had determined that the embedded conversion option in the 2022 Convertible Notes was not required to be separately accounted for as a derivative under GAAP.

The 2022 Convertible Notes were unsecured obligations and ranked senior in right of payment to the Company’s existing and future indebtedness, if any, that was expressly subordinated in right of payment to the 2022 Convertible Notes; equal in right of payment to the Company’s existing and future unsecured indebtedness that was not so subordinated; effectively junior in right of payment to any of the Company’s secured indebtedness (including existing unsecured indebtedness that the Company later secured) to the extent of the value of the assets securing such indebtedness; and structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company’s subsidiaries and financing vehicles. As reflected in Note 11. Earnings (Loss) Per Share, the issuance was considered part of the if-converted method for calculation of diluted earnings per share.

The following table summarizes the interest expense, amortization of financing costs and amortization of premium incurred on the 2022 Convertible Notes for the three and nine months ended September 30, 2025:

Three Months EndedNine Months Ended
September 30, 2025(1)September 30, 2025(1)
Interest expense$4,852$14,570
Amortization of financing costs$430$1,282
Amortization of premium$(29)$(74)
Weighted average interest rate7.5%7.5%
Effective interest rate8.1%8.1%
Average debt outstanding$258,777$259,022

(1)On October 15, 2025, the 2022 Convertible Notes matured and were repaid.

Unsecured Notes

On January 29, 2021, the Company issued $200,000 in aggregate principal amount offive-year unsecured notes that matured on January 29, 2026 (the "January 2026 Notes") pursuant to an amended and restated note purchase agreement, dated September 30, 2016 ("the NPA") and a fifth supplement to the NPA (the "Fifth Supplement"). On January 29, 2026, the Company fully repaid $200,000 in aggregate principal amount of issued and outstanding January 2026 Notes. On June 15, 2022, the Company issued $75,000 in aggregate principal amount offive-year unsecured notes that mature on June 15, 2027 (the "June 2027 Notes") pursuant to the NPA and a sixth supplement to the NPA (the "Sixth Supplement"). The NPA provides for future issuances of unsecured notes in separate series or tranches.

The January 2026 Notes bore interest at an annual rate of 3.875%. The June 2027 Notes bear interest at an annual rate of 5.900%, payable semi-annually in arrears on June 15 and December 15 of each year. These interest rates are subject to increase in the event that: (i) subject to certain exceptions, the underlying unsecured notes or the Company ceases to have an investment grade rating or (ii) the aggregate amount of the Company’s unsecured debt falls below $150,000. In each such event, the Company has the option to offer to prepay the underlying unsecured notes at par, in which case holders of the underlying unsecured notes who accept the offer would not receive the increased interest rate. In addition, the Company is obligated to offer to prepay the underlying unsecured notes at par if the Investment Adviser, or an affiliate thereof, ceases to be the Company’s investment adviser or if certain change in control events occur with respect to the Investment Adviser.

The NPA contains customary terms and conditions for unsecured notes issued in a private placement, including, without limitation, an option to offer to prepay all or a portion of the unsecured notes under its governance at par (plus a make-whole amount, if applicable), affirmative and negative covenants such as information reporting, maintenance of the Company’s status as a BDC under the 1940 Act and a RIC under the Code, minimum stockholders’ equity, minimum asset coverage ratio, and prohibitions on certain fundamental changes at the Company or any subsidiary guarantor, as well as customary events of default with customary cure and notice, including, without limitation, nonpayment, misrepresentation in a material respect, breach of covenant, cross-default under other indebtedness of the Company or certain significant subsidiaries, certain judgments and orders, and certain events of bankruptcy. The Fifth Supplement and Sixth Supplement both include additional financial covenants related to asset coverage as well as other terms.

On November 13, 2023, the Company closed a registered public offering of $115,000 in aggregate principal amount of 8.250% notes that mature on November 15, 2028 (the "November 2028 Notes"), pursuant to a base indenture and fourth supplemental indenture thereto dated November 13, 2023 (the "Fourth Supplemental Indenture") between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee.

The November 2028 Notes bear interest at an annual rate of 8.250%, payable quarterly on February 15, May 15, August 15 and November 15 of each year. The November 2028 Notes are listed on NASDAQ and trade under the trading symbol "NMFCZ".

The Company may redeem the November 2028 Notes, in whole or in part, at any time, or from time to time, at its option on or after November 15, 2025 at the redemption price of par, plus accrued interest.

No sinking fund provision is provided for the November 2028 Notes and holders of the November 2028 Notes have no option to have their November 2028 Notes repaid prior to the stated maturity date.

On February 1, 2024, the Company issued $300,000 in aggregate principal amount of its 6.875% notes that mature on February 1, 2029 (the "February 2029 Notes") pursuant to a base indenture and fifth supplemental indenture thereto dated February 1, 2024 (the "Fifth Supplemental Indenture"). The February 2029 Notes bear interest at an annual rate of 6.875%, payable semi-annually on February 1 and August 1 of each year. The Company may redeem the February 2029 Notes, in whole or in part, at any time prior to January 1, 2029, at par plus a "make-whole" premium, and thereafter at par, plus accrued interest.

On September 26, 2024, the Company issued $300,000 in aggregate principal amount of its 6.200% notes that mature on October 15, 2027 (the "October 2027 Notes", together with the January 2026 Notes, June 2027 Notes, November 2028 Notes and February 2029 Notes, the "Unsecured Notes") pursuant to a base indenture and sixth supplemental indenture thereto dated September 26, 2024 (together, with the Fourth Supplemental Indenture and the Fifth Supplemental Indenture, the "Indenture"). The October 2027 Notes bear interest at an annual rate of 6.200%, payable semi-annually on April 15 and October 15 of each year, beginning on April 15, 2025. The Company may redeem the October 2027 Notes, in whole or in part, at any time prior to October 15, 2027, at par plus a "make-whole" premium and accrued interest.

On June 18, 2026, the Company entered into the seventh supplement to the NPA (the “Seventh Supplement”) with certain institutional investors, providing for the private placement of $150,000 in aggregate principal amount of senior notes, consisting of (i) $40,000 aggregate principal amount of 7.28% Senior Fixed Rate Notes, Tranche A, due October 2028 (the “October 2028 Notes”), (ii) $35,000 aggregate principal amount of 7.76% Senior Fixed Rate Notes, Tranche B, due October 2031 (the “October 2031A Notes”), and (iii) $75,000 aggregate principal amount of Senior Floating Rate Notes, Tranche C, due October 2031, which bear interest at a rate of SOFR plus 3.66% (the “October 2031B Notes”). The closing and funding of the October 2028 Notes, October 2031A Notes and October 2031B Notes occurred on October 1, 2026. As of September 30, 2026, none of the October 2028 Notes, October 2031A and October 2031B Notes had been funded under the NPA, as supplemented by the Seventh Supplement.

The Unsecured Notes are unsecured obligations and rank senior in right of payment to the Company’s existing and future indebtedness, if any, that is expressly subordinated in right of payment to the Unsecured Notes; equal in right of payment to the Company’s existing and future unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of the Company’s secured indebtedness (including existing unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness; and structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company’s subsidiaries and financing vehicles.

The following table summarizes the interest expense and amortization of financing costs incurred on the Unsecured Notes for the three and nine months ended September 30, 2026 and September 30, 2025:

Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Interest expense(1)$13,505$16,385$40,748$47,979
Amortization of financing costs$766$827$2,301$2,440
Amortization of discount$314$314$932$932
Weighted average interest rate6.7%6.5%6.6%6.5%
Effective interest rate7.4%7.1%7.2%6.9%
Average debt outstanding$790,000$990,000$811,245$990,000

(1)Interest expense includes net expense recognized on fair value hedges.

As of September 30, 2026 and December 31, 2025, the outstanding balance on the Unsecured Notes was $778,013 and $991,585, respectively, and the Company was in compliance with the terms of the NPA and Indenture as of such dates, as applicable.

In connection with the issuance of the February 2029 Notes, the Company entered into an interest rate swap on March 22, 2024 with Morgan Stanley Bank N.A., in which the Company receives a fixed interest rate of 6.875% and pays a floating interest rate of one-month SOFR plus 2.8183% on the notional amount of $300,000. In connection with the issuance of the October 2027 Notes, the Company entered into an interest rate swap on September 23, 2024 with Morgan Stanley Bank N.A., in which the Company receives a fixed interest rate of 6.200% and pays a floating rate of one-month SOFR plus 2.8820% on the notional amount of $300,000. The Company designates interest rate swaps as fair value hedges in a qualifying fair value hedge accounting relationship to mitigate risk of changes in the fair value of financial liabilities due to interest rate risk. As a result, the Company will present changes in fair value of the hedging instruments and the related hedged items in interest expense within the Company’s Consolidated Statements of Operations.

The Company recorded and formally documented all hedging relationships, its risk management objective and strategy upon entering into each hedging relationship. For each hedging relationship, the Company performs quarterly quantitative assessments of the hedge effectiveness to assess that the hedging relationships are highly effective in offsetting changes in fair values of hedged items and whether the relationship is expected to continue to be highly effective in the future. To the extent the changes in fair value of the derivative do not offset the changes in fair value of the hedged item, the difference is recognized. The corresponding adjustment to the hedged asset or liability is included in the basis of the hedged item, while the corresponding change in the fair value of the derivative instrument is recorded as an adjustment to "Derivative assets at fair value" or "Derivative liabilities at fair value", as applicable.

If a hedge relationship is de-designated or if hedge accounting is discontinued because the hedged item no longer exists, the derivative will continue to be recorded as a "Derivative asset at fair value" or "Derivative liability at fair value" in the Consolidated Statements of Assets and Liabilities at its fair value, with changes in fair value recognized in net change in unrealized appreciation (depreciation).

The following table presents the effect of hedging derivative instruments on the Consolidated Statements of Operations and the total amounts for the respective line items affected:

Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
(Losses) gains on fair value hedging relationship:
Interest rate swap contract:
Interest expense recognized on derivative$(206)$(1,182)$(242)$(3,184)
(Losses) gains recognized on derivative(6,362)719(14,576)12,436
Gains (losses) recognized on hedged item6,347(698)14,504(11,564)
Net expense recognized on fair value hedge$(221)$(1,161)$(314)$(2,312)

The following table summarizes the carrying value of the Company's hedged assets and liabilities in fair value hedges and the associated cumulative basis adjustments included in those carrying values as of September 30, 2026 and December 31, 2025.

As of
September 30, 2026December 31, 2025
DescriptionCarrying ValueCumulative Amount of Basis AdjustmentCarrying ValueCumulative Amount of Basis Adjustment
February 2029 Notes$292,551$5,995$303,000$(4,918)
October 2027 Notes295,4623,887298,585296

The Company’s derivative instrument contracts are subject to ISDA Master Agreements which contain certain covenants and other provisions upon the occurrence of specific credit-risk-related events which may allow the counterparties to terminate derivatives contracts if the Company fails to maintain sufficient asset coverage for its derivative contracts or upon certain credit events. As a result, the hedging relationship terminates and is immediately accelerated and deemed payable pursuant to the ISDA Master Agreement.

The aggregate fair values of all derivative instruments with any credit-risk-related contingent features that was a net liability of $9,296 as of September 30, 2026 and a net asset of $5,281 as of December 31, 2025, for which the Company had posted collateral of $60 for September 30, 2026 and Morgan Stanley Bank N.A. had posted collateral of $14,630 for December 31, 2025. The Company does not have any derivatives that are not designated as hedging instruments.

SBA-guaranteed debentures—On August 1, 2014, August 25, 2017 and July 15, 2025, respectively, SBIC I, SBIC II and SBIC III received licenses from the SBA to operate as SBICs.

These SBIC licenses allow each of SBIC I, SBIC II and SBIC III to obtain leverage in the form of SBA-guaranteed debentures, subject to the SBA's customary commitment and draw application procedures. SBA debentures are non-recourse, interest-only debentures with interest payable semi-annually and have aten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with ten-year maturities. The SBA, as a creditor, will have a superior claim to the assets of SBIC I, SBIC II and SBIC III over the Company's stockholders in the event SBIC I, SBIC II and SBIC III are liquidated or the SBA exercises its remedies upon an event of default.

The following table summarizes the Company’s SBA-guaranteed debentures repayments as of September 30, 2026:

Issuance DateMaturity DateRepayment DateRepayment Amount
Fixed SBA-guaranteed debentures(1):
March 25, 2015March 1, 2025February 28, 2025$37,500
September 23, 2015September 1, 2025August 29, 202566,295
March 23, 2016March 1, 2026February 27, 202613,950
September 21, 2016September 1, 2026August 31, 20264,000
September 20, 2017September 1, 2027August 31, 202613,000
March 21, 2018March 1, 2028August 31, 202615,255
Fixed SBA-guaranteed debentures(2):
September 19, 2018September 1, 2028March 2, 202613,000
September 19, 2018September 1, 2028August 31, 20262,000
September 25, 2019September 1, 2029August 31, 202615,000
Total SBA-guaranteed debentures repaid$180,000

(1)SBA-guaranteed debentures repaid by SBIC I

(2)SBA-guaranteed debentures repaid by SBIC II

As of September 30, 2026 and December 31, 2025, SBIC I had regulatory capital of $75,000 and $75,000, respectively, and SBA-guaranteed debentures outstanding of $0 and $46,205, respectively.

As of September 30, 2026 and December 31, 2025, SBIC II had regulatory capital of $75,000 and $75,000, respectively, and SBA-guaranteed debentures outstanding of $120,000 and $150,000, respectively. The SBA-guaranteed debentures incur upfront fees of 3.435%, which consist of a 1.00% commitment fee and a 2.435% issuance discount.

As of September 30, 2026 and December 31, 2025, SBIC III had regulatory capital of $3,375 and $3,375, respectively. SBIC III hadno SBA-guaranteed debentures outstanding as of September 30, 2026 and December 31, 2025.

The following table summarizes the Company’s SBA-guaranteed debentures as of September 30, 2026:

Issuance DateMaturity DateDebenture AmountInterest RateSBA Annual Charge
Fixed SBA-guaranteed debentures(1):
September 25, 2019September 1, 2029$4,0002.283%0.222%
March 25, 2020March 1, 203041,0002.078%0.222%
March 25, 2020March 1, 203024,0002.078%0.275%
September 23, 2020September 1, 203051,0001.034%0.275%
Total SBA-guaranteed debentures$120,000

(1)As of September 30, 2026, the outstanding SBA-guaranteed debentures were issued by SBIC II. All SBA-guaranteed debentures that were issued by SBIC I were repaid.

Prior to pooling, the SBA-guaranteed debentures bear interest at an interim interest rate equal to the Federal Home Loan Bank of Chicago's Fixed Regular Advance Rate (Bank Advance Rate), plus 41 basis points. Once pooled (which, effective June 2026 occurs quarterly each year), the SBA-guaranteed debentures bear interest at a fixed rate that is set to the current 10-year treasury rate plus a spread at each pooling date.

The following table summarizes the interest expense and amortization of financing costs incurred on the SBA-guaranteed debentures for the three and nine months ended September 30, 2026 and September 30, 2025:

Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Interest expense$843$1,588$2,910$5,247
Amortization of financing costs$415$203$818$659
Weighted average interest rate2.2%2.6%2.3%2.7%
Effective interest rate3.3%3.0%2.9%3.0%
Average debt outstanding$153,194$240,882$169,667$263,319

The SBIC program is designed to stimulate the flow of private investor capital into eligible small businesses, as defined by SBA regulations that, among other things: require SBICs to invest in eligible small businesses and invest at least 25.0% of investment capital in eligible smaller enterprises (as defined by the SBA regulations), place certain limitations on the financing terms of investments, regulate the types of financing provided by an SBIC, prohibit investments in small businesses with certain characteristics or in certain industries, and require capitalization thresholds that limit distributions to the Company. SBICs are subject to periodic examination by an SBA examiner to determine the SBIC's compliance with the relevant SBA regulations and an annual financial audit of its financial statements that are prepared on a basis of accounting other than GAAP (such as ASC 820) and in accordance with the SBA's SBIC Valuation Guidelines by an independent auditor.

Leverage risk factors—The Company utilizes and may utilize leverage to the maximum extent permitted by the law for investment and other general business purposes. The Company's lenders will have fixed dollar claims on certain assets that are superior to the claims of the Company's common stockholders, and the Company would expect such lenders to seek recovery against these assets in the event of a default. The use of leverage also magnifies the potential for gain or loss on amounts invested. Leverage may magnify interest rate risk (particularly on the Company's fixed-rate investments), which is the risk that the prices of portfolio investments will fall or rise if market interest rates for those types of securities rise or fall. As a result, leverage may cause greater changes in the Company's net asset value. Similarly, leverage may cause a sharper decline in the Company's income than if the Company had not borrowed. Such a decline could negatively affect the Company's ability to make distributions to its stockholders. Leverage is generally considered a speculative investment technique. The Company's ability to service any debt incurred will depend largely on financial performance and will be subject to prevailing economic conditions and competitive pressures.

Note 8. Regulation

The Company has elected to be treated, and intends to comply with the requirements to continue to qualify annually, as a RIC under Subchapter M of the Code. In order to continue to qualify and be subject to tax treatment as a RIC, among other things, the Company is generally required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each year. The Company, among other things, intends to make and will continue to make the requisite distributions to its stockholders, which will generally relieve the Company from U.S. federal, state, and local income taxes (excluding excise taxes which may be imposed under the Code).

Additionally, as a BDC, the Company must not acquire any assets other than "qualifying assets" as defined in Section 55(a) of the 1940 Act unless, at the time the acquisition is made, at least 70.0% of its total assets are qualifying assets (with certain limited exceptions). In addition, the Company must offer to make available to all "eligible portfolio companies" (as defined in the 1940 Act) significant managerial assistance.

Note 9. Commitments and Contingencies

In the normal course of business, the Company may enter into contracts that contain a variety of representations and warranties and which provide general indemnifications. The Company may also enter into future funding commitments such as revolving credit facilities, bridge financing commitments or delayed draw commitments. As of September 30, 2026, the Company had unfunded commitments on revolving credit facilities of $112,946, which included €1,196 denominated in EUR that has been translated to U.S. dollars, no outstanding bridge financing commitments and other future funding commitments of $31,776, which included €6,411 denominated in EUR that has been translated to U.S. dollars. As of December 31, 2025, the Company had unfunded commitments on revolving credit facilities of $133,534, which included €1,092 denominated in EUR that has been translated to U.S. dollars, no outstanding bridge financing commitments and other future funding commitments of $77,602, which included €6,411 denominated in EUR that has been translated to U.S. dollars. The unfunded commitments on revolving credit facilities and delayed draws are disclosed on the Company’s Consolidated Schedules of Investments.

The Company also had revolving borrowings available under the Holdings Credit Facility, the NMFC Credit Facility and the Unsecured Management Company Revolver, as of September 30, 2026 and December 31, 2025. In addition, as of September 30, 2026, $150,000 of unsecured notes had not yet been funded under the Seventh Supplement to the NPA, consisting of $40,000 of October 2028 Notes, $35,000 of October 2031A Notes and $75,000 of October 2031B Notes. These notes were funded in full on October 1, 2026. As of December 31, 2025, there were no unfunded notes. See Note 7. Borrowings, for details.

The Company may from time to time enter into financing commitment letters. As of September 30, 2026 and December 31, 2025, the Company had commitment letters to purchase investments in the aggregate par amount of $10,505 and $4,727, respectively, which could require funding in the future.

Note 10. Net Assets

The table below illustrates the effect of certain transactions on the net asset accounts of the Company during the three and nine months ended September 30, 2026:

Accumulated Undistributed (Overdistributed) Earnings
Common Stock · Treasury Stock · Paid inCapital inExcess · AccumulatedNet Investment · Accumulated Net Realized · Net Unrealized Appreciation · Total Net Assets · Non-ControllingInterest in · Total
SharesPar Amountat Costof ParIncome(Losses) Gains(Depreciation)of NMFCNMNLCNet Assets
Net assets at December 31, 2025102,638,388$1,079$(51,952)$1,354,726$192,583$(98,121)$(216,138)$1,182,177$6,079$1,188,256
Repurchases of commonstock under theRepurchase Program(7,063,237)—(56,597)————(56,597)—(56,597)
Distributions declared————(31,150)——(31,150)(90)(31,240)
Contributions related to non-controlling interest in NMNLC————————300300
Net increase (decrease) in net assets resulting from operations————30,517(32,010)(49,435)(50,928)179(50,749)
Net assets at March 31, 202695,575,151$1,079$(108,549)$1,354,726$191,950$(130,131)$(265,573)$1,043,502$6,468$1,049,970
Repurchases of commonstock under theRepurchase Program(1,122,761)—(8,966)————(8,966)—(8,966)
Distributions declared————(23,612)——(23,612)(90)(23,702)
Net increase (decrease) in net assets resulting from operations————24,502(44,984)37,73917,25725617,513
Net assets at June 30, 202694,452,390$1,079$(117,515)$1,354,726$192,840$(175,115)$(227,834)$1,028,181$6,634$1,034,815
Distributions declared————(23,613)——(23,613)(737)(24,350)
Net increase (decrease) in net assets resulting from operations————23,580(532)(19,569)3,4792643,743
Net assets at September 30, 202694,452,390$1,079$(117,515)$1,354,726$192,807$(175,647)$(247,403)$1,008,047$6,161$1,014,208

The table below illustrates the effect of certain transactions on the net asset accounts of the Company during the three and nine months ended September 30, 2025:

Accumulated Undistributed (Overdistributed) Earnings
Common Stock · Treasury Stock · Paid inCapital in Excess · AccumulatedNet Investment · Accumulated Net Realized (Losses) · Net Unrealized Appreciation · Total Net Assets · Non-Controlling Interest in · Total
SharesPar Amountat Costof ParIncomeGains(Depreciation)of NMFCNMNLCNet Assets
Net assets at December 31, 2024107,851,415$1,079$—$1,365,852$181,266$(141,279)$(53,579)$1,353,339$5,952$1,359,291
Offering costs———(28)———(28)—(28)
Distributions declared————(34,512)——(34,512)(90)(34,602)
Net increase (decrease) in net assets resulting from operations————34,52437,825(48,936)23,41310423,517
Net assets at March 31, 2025107,851,415$1,079$—$1,365,824$181,278$(103,454)$(102,515)$1,342,212$5,966$1,348,178
Repurchases ofcommon stockunder OldRepurchaseProgram(925,216)—(9,642)————(9,642)—(9,642)
Conversion of2022 ConvertibleNotes to Shares514—————————
Offering costs———14———14—14
Distributions declared————(34,499)——(34,499)(90)(34,589)
Net increase (decrease) in net assets resulting from operations————34,46813,389(40,083)7,7741017,875
Net assets at June 30, 2025106,926,713$1,079$(9,642)$1,365,838$181,247$(90,065)$(142,598)$1,305,859$5,977$1,311,836
Repurchases ofcommon stockunder OldRepurchaseProgram(2,737,377)—(27,611)————(27,611)—(27,611)
Conversion of2022 ConvertibleNotes to Shares———7———7—7
Offering costs———4———4—4
Distributions declared————(33,822)——(33,822)(90)(33,912)
Net increase (decrease) in net assets resulting from operations————33,9259(21,745)12,18915312,342
Net assets at September 30, 2025104,189,336$1,079$(37,253)$1,365,849$181,350$(90,056)$(164,343)$1,256,626$6,040$1,262,666

On February 4, 2016, the Company's board of directors authorized a program for the purpose of repurchasing up to $50,000 worth of common stock (the "Old Repurchase Program"). The Old Repurchase Program terminated on October 8, 2025 upon the repurchase of $50,000 of common stock. On October 23, 2025, the Company's board of directors authorized a new program for the purpose of repurchasing up to $100,000 worth of common stock (the "Repurchase Program"). On April 28, 2026, the Company's board of directors authorized the repurchase of up to an additional $50,000 of the Company's common stock.

Under the Old Repurchase Program and the Repurchase Program, the Company is permitted, but not obligated, to repurchase outstanding common stock in the open market from time to time, provided that the Company complied with its code of ethics and the guidelines specified in Rule 10b-18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") including certain price, market volume and timing constraints. In addition, any repurchases are conducted in accordance with the 1940 Act. The Company expects the Repurchase Program to be in place until the earlier of December 31, 2027 or until $150,000 worth of common stock has been repurchased.

During the three and nine months ended September 30, 2026, no shares and approximately $65,563 of common stock was repurchased under the Repurchase Program, respectively. As of September 30, 2026, approximately $79,538 remained available under the Repurchase Program.

On November 3, 2021, the Company entered into an equity distribution agreement, as amended on May 18, 2023, August 23, 2023, June 27, 2024 and August 1, 2024 (the “Distribution Agreement”), with B. Riley Securities, Inc. and Raymond James & Associates, Inc. On August 1, 2024, the Company entered into Amendment No. 4 to the Distribution Agreement with B. Riley Securities, Inc., Raymond James & Associates, Inc., and Citizens JMP Securities, LLC (collectively, the "Agents") for the purpose of adding Citizens JMP Securities, LLC as an Agent. The Distribution Agreement originally provided that the Company may issue and sell its shares from time to time through the Agents, up to $250,000 worth of its common stock by means of at-the-market ("ATM") offerings. As of the amendment on June 27, 2024, the Company increased the maximum amount of shares to be sold through the ATM program from $250,000 to $400,000.

For the three and nine months ended September 30, 2026 and September 30, 2025, the Company did not sell any shares of common stock under the Distribution Agreement.

The Company generally uses net proceeds from these offerings to make investments, to pay down liabilities and for general corporate purposes. As of September 30, 2026, shares representing approximately $257,991 of its common stock remain available for issuance and sale under the Distribution Agreement.

Note 11. Earnings (Loss) Per Share

The following information sets forth the computation of basic and diluted net increase (decrease) in the Company’s net assets per share resulting from operations for the three and nine months ended September 30, 2026 and September 30, 2025:

Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Earnings per share—basic
Numerator for basic earnings (loss) per share:$3,479$12,189$(30,192)$43,376
Denominator for basic weighted average share:94,452,390106,016,54296,471,368107,199,318
Basic earnings (loss) per share:$0.04$0.11$(0.31)$0.40
Earnings per share—diluted(1)
Numerator for increase (decrease) in net assets per share$3,479$12,189$(30,192)$43,376
Adjustment for interest on 2022 Convertible Notes and incentive fees, net(2)(3)—4,482—12,741
Numerator for diluted earnings (loss) per share:$3,479$16,671$(30,192)$56,117
Denominator for basic weighted average share94,452,390106,016,54296,471,368107,199,318
Adjustment for dilutive effect of 2022 Convertible Notes(2)—19,020,154—19,001,718
Denominator for diluted weighted average share94,452,390125,036,69696,471,368126,201,036
Diluted earnings (loss) per share:$0.04$0.11$(0.31)$0.40

(1)In applying the if-converted method, conversion is not assumed for purposes of computing diluted earnings per share if the effect would be anti-dilutive. For the three and nine months ended September 30, 2025, there was anti-dilution.

(2)For the three and nine months ended September 30, 2026, the Company had no convertible notes outstanding.

(3)In applying the if-converted method, the adjustment for incentive fees includes the impact of any incentive fee waived during the period. See Note 5. Agreements, for details.

Note 12. Financial Highlights

The following information sets forth the Company's financial highlights for the nine months ended September 30, 2026 and September 30, 2025:

Nine Months Ended
September 30, 2026September 30, 2025
Per share data(1):
Net asset value, January 1, 2026 and January 1, 2025, respectively$11.52$12.55
Net investment income0.810.96
Net realized and unrealized losses(1.12)(0.56)
Total net (decrease) increase(0.31)0.40
Repurchases of common stock0.280.07
Distributions declared to stockholders from net investment income(2)(0.82)(0.96)
Net asset value, September 30, 2026 and September 30, 2025, respectively$10.67$12.06
Per share market value, September 30, 2026 and September 30, 2025, respectively$6.92$9.64
Total return based on market value(3)(16.15)%(6.24)%
Total return based on net asset value(4)(0.17)%3.86%
Shares outstanding at end of period94,452,390104,189,336
Average weighted shares outstanding for the period96,471,368107,199,318
Average net assets for the period$1,075,132$1,329,882
Ratio to average net assets(5):
Net investment income9.77%10.35%
Total expenses, before waivers/reimbursements15.00%15.62%
Total expenses, net of waivers/reimbursements13.89%14.72%
Average debt outstanding—Unsecured Notes$811,245$990,000
Average debt outstanding—Holdings Credit Facility398,377285,184
Average debt outstanding—SBA-guaranteed debentures169,667263,319
Average debt outstanding—NMFC Credit Facility(6)58,15529,879
Average debt outstanding—2022 Convertible Notes(7)—259,022
Asset coverage ratio(8)184.03%179.09%
Portfolio turnover8.39%12.18%

(1)Per share data is based on weighted average shares outstanding for the respective period (except for distributions declared to stockholders, which is based on actual rate per share).

(2)The specific tax characteristics of the Company’s distributions will be reported to stockholders after the end of the calendar year.

(3)Total return is calculated assuming a purchase of common stock at the opening of the first day of the year and a sale on the closing of the last business day of the period. Dividends and distributions, if any, are assumed for purposes of this calculation, to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total return does not reflect sales load.

(4)Total return is calculated assuming a purchase at net asset value on the opening of the first day of the year and a sale at net asset value on the last day of the period. Dividends and distributions, if any, are assumed for purposes of this calculation, to be reinvested at the net asset value on the last day of the respective quarter. Total return does not reflect sales load.

(5)Interim periods are annualized.

(6)Under the NMFC Credit Facility, the Company may borrow in U.S. dollars or certain other permitted currencies. As of September 30, 2026 and September 30, 2025, the Company had borrowings denominated in EUR of €16,512 and €16,512, respectively, and borrowings denominated in GBP of £8,666 and £8,666, respectively, that have been translated to U.S. dollars.

(7)On October 15, 2025, the Company repaid the outstanding principal on the 2022 Convertible Notes, which matured on October 15, 2025.

(8)On November 5, 2014, the Company received exemptive relief from the SEC allowing the Company to modify the asset coverage requirement to exclude the SBA-guaranteed debentures from this calculation.

Note 13. Recent Accounting Standards Updates

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (“ASU 2024-03”), which requires disaggregated disclosure of certain costs and expenses, including purchases of inventory, employee compensation, depreciation, amortization and depletion, within relevant income statement captions. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods beginning with the first quarter ended March 31, 2028. Early adoption and retrospective application are permitted. The Company is currently assessing the impact of this guidance; however, the Company does not expect a material impact on its consolidated financial statements.

In November 2025, the FASB issued ASU 2025-09, Derivatives and Hedging - Hedge Accounting Improvements ("ASU 2025-09"), which enhances certain aspects of the guidance by (i) expanding the hedged risks permitted to be aggregated in a group of individual forecasted transactions in a cash flow hedge, (ii) providing a model to facilitate the application of cash flow hedge accounting to forecasted interest payments on choose-your-rate debt instruments, (iii) expanding hedge accounting for forecasted purchases and sales of nonfinancial assets, (iv) eliminating the requirement to apply the net written option test to a compound derivative comprising a swap and a written option designated as the hedging instrument in a hedge of interest rate risk, and (v) eliminating the recognition and presentation mismatch related to dual hedge strategies. ASU 2025-09 is effective for fiscal years beginning after December 15, 2026, and interim periods within those fiscal years. Early adoption is permitted and prospective application for all hedging relationships is required. The Company is currently assessing the impact of this guidance and does not expect a material impact on its consolidated financial statements.

Note 14. Segment Reporting

The Company operates through a single operating and reporting segment with an investment objective to generate both current income and capital appreciation through debt and equity investments. The chief operating decision maker ("CODM") is the Company’s Chief Executive Officer and the CODM assesses the performance and makes operating decisions of the Company on a consolidated basis primarily based on the Company’s net increase in net assets resulting from operations (“net income”). In addition to numerous other factors and metrics, the CODM utilizes net income as a key metric in determining the amount of dividends to be distributed to the Company’s stockholders. As the Company’s operations comprise a single reporting segment, the segment assets are reflected on the accompanying Consolidated Statements of Assets and Liabilities as “total assets” and the significant segment expenses are listed on the accompanying Consolidated Statements of Operations.

Note 15. Subsequent Events

On October 1, 2026, the October 2028 Notes, October 2031A Notes and October 2031B Notes were funded in full in the aggregate amount of $150,000. In conjunction with the funding of the October 2028 Notes and October 2031A Notes, the Company entered into an interest rate swap on October 1, 2026 with Morgan Stanley Bank N.A., in which (i) for the October 2028 Notes, the Company receives fixed interest of 7.28% and pays a floating interest rate of one-month SOFR plus 2.50% on the notional amount of $40,000 and (ii) for the October 2031A Notes, the Company receives fixed interest of 7.76% and pays a floating interest rate of one-month SOFR plus 2.89% on the notional amount of $35,000.

On October 2, 2026, the Company reduced the commitment amount under the Holdings Credit Facility from $450,000 to $350,000, in advance of the scheduled October 26, 2026 reduction date, and repaid the outstanding borrowings in excess of $350,000.

On October 20, 2026, the Company's board of directors extended the Repurchase Program, which is expected to remain in place until the earlier of December 31, 2027 or until $150,000 worth of the Company's common stock has been repurchased.

On October 20, 2026, the Company’s board of directors declared a fourth quarter 2026 distribution of $0.25 per share, payable on December 31, 2026 to holders of record as of December 17, 2026.

On October 20, 2026, the SBA confirmed that SBIC I had repaid all outstanding debentures and approved SBIC I's request to surrender its license to operate as an SBIC.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.